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Abstract
All organisms are composed of a multitude of cell types, having each a specific task to accom-
plish. This cell-to-cell heterogeneity results from a complex process of differentiation initiated by
the interpretation of intra and extracellular cues by signalling cascades. Therefore, it becomes
fundamental to study the signal processing driven by signalling cascades, in order to understand
how cells organise during development, but also to comprehend how and why signals are some-
times misinterpreted and lead to diseases such as cancer. MAPK pathways belong to a very
well-conserved family of signalling cascades, known to be mostly implicated in the adaptation
to environmental stimuli and to regulate various key physiological processes. The various com-
ponents of the MAPK pathways are well defined. However, we still need to understand how
signalling cascades cross-communicate with each other and how this leads to different cell-fate
decision making. The limitation is mostly technical, as such investigation would require to dy-
namically and simultaneously investigate the activity state of MAPK components in live single
cells. The aim of this thesis was to build a new kind of assay, enabling to extract these inform-
ation. Here, I described the design of the synthetic protein SKARS, that relocates from the
nucleus to the cytoplasm following specific phosphorylation. This synthetic protein is composed
of a docking site (DS), that enables a specific interaction with a MAP kinase, a nuclear local-
isation sequence (NLS), that promotes an active nuclear importation, and a fluorescent protein
(FP), that allows to determine its sub-cellular localisation. Once the cell activates the MAPK,
the NLS gets inhibited by phosphorylation, which leads to the cytoplasmic accumulation of the
fluorescent protein. This nucleus-to-cytoplasm shuttling is used as a proxy for MAPK activity. In
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order to demonstrate this, we applied this technology in the mating pathway study of the model
organism Saccharomyces cerevisiae. By combining time-lapse fluorescent microscopy with com-
putational analysis, we extracted the dynamic MAPK activity in hundreds of cells, and observed
that when cells are exposed to exogenous pheromone, the MAPK is differentially activated from
one cell to another. Using the Whi5 transcription factor as a sensor for the cell cycle progression,
we showed that these different signal patterns are specific to the cell-cycle stage of the cell. The
MAPK is fully activated in G1, inhibited in S, G2 and M and transiently activated during the
transition between G1 and S. Moreover, single cell analysis of mutants let us conclude that the
model describing how the cell cycle regulates the mating pathway is incomplete. To conclude,
we showed that the parallel measurement of multiple signalling cascades is a valuable strategy
enlighten very subtle pathway cross-regulation events. Thanks to the straightforward structure
of the SKARS, crosstalk mechanisms between signalling cascades can be assessed, by combining
multiple sensors in the same cell. We are currently applying this technology to mammalian cells,
and strongly believe that this technique can be an advantage in fields such as development or
cancer research.
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Résumé scientifique
Tous les organismes sont composés d’une multitude de cellules ayant chacune une tâche spéci-
fique à accomplir. Cette hétérogénéité résulte d’un processus complexe de différenciation initié
par l’analyse de signaux intracellulaires et extracellulaires par des cascades de signalisation. Par
conséquent, il devient fondamental d’étudier le traitement du signal par les voies de signalisation
pour comprendre comment les cellules s’organisent pendant le développement, mais aussi pour
comprendre comment et pourquoi ces signaux peuvent parfois être mal interprétés et entraîner
l’apparition de maladies telles que le cancer. Les voies impliquant les MAP Kinases (MAPK)
appartiennent à une famille très bien conservée de cascades de signalisation connues pour leurs
rôles dans l’adaptation aux stimuli environnementaux et dans la régulation de divers processus
physiologiques clés. Les différents composants des voies impliquant les MAPK commencent à être
bien connus. Cependant, nous ne comprenons toujours pas comment les cascades de signalisa-
tion s’autorégulent et comment cela conduit à divers comportements cellulaires. La limitation est
principalement technique, car une telle recherche nécessiterait de sonder l’état d’activité des com-
posants des cascades de MAPK, dynamiquement et simultanément dans chaque cellule vivante.
L’objectif de cette thèse fut de construire un nouveau type de senseur permettant d’extraire
ces informations. Dans ce manuscrit, nous décrivons le design, ainsi qu’une application de la
protéine synthétique SKARS (Synthetic Kinase Activity Relocation Sensor). Elle a été conçue
pour se déplacer du noyau vers le cytoplasme après avoir été spécifiquement phosphorylée par
la kinase d’intérêt. La protéine est composée d’un domaine de docking (DS), qui permet une
interaction spécifique avec une MAPK, un signal de localisation nucléaire (NLS), qui favorise
9
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une importation active dans le noyau et une protéine fluorescente pour observer sa position dans
les compartiments cellulaires. Une fois que la cellule active la MAPK, le NLS est inhibé après
phosphorylation ce qui conduit à l’accumulation de la protéine fluorescente dans le cytoplasme.
Le passage du noyau au cytoplasme est utilisé comme mesure de l’activité MAPK. Comme preuve
de concept, nous avons appliqué cette technologie dans l’étude de la voie d’accouplement chez
l’organisme modèle Saccharomyces cerevisiae. En combinant la microscopie à fluorescence en
temps réel avec une analyse informatique, nous avons extrait l’activité dynamique de la MAPK
dans des centaines de cellules et avons observé que lorsque les cellules sont exposées à de la
phéromone exogène, la MAPK s’active de manière différente d’une cellule à l’autre. En utilisant
le facteur de transcription Whi5 comme senseur de la progression du cycle cellulaire, nous avons
montré que ces différents types de trace d’activité de MAPK sont spécifiques à chaque phase
du cycle cellulaire dans laquelle se trouve la cellule. La MAPK est entièrement activée en G1,
inhibée en S, G2 et M et activée de manière transitoire à l’interaction entre G1 et S. De plus,
l’analyse de cellule mutantes individuellement nous a permis de conclure que le modèle décrivant
le mécanisme de régulation de la voie d’accouplement par le cycle cellulaire est incomplet. Pour
conclure, la mesure en parallèle de plusieurs cascades de signalisation est une stratégie intéres-
sante pour détecter de fins événements de régulation entre les voies de signalisation. Grâce à sa
structure modulable, plusieurs SKARS peuvent être construits et combinés dans le but d’étudier
les mécanismes de régulation croisés entre les cascades de signalisation. Nous appliquons actuel-
lement cette technologie aux cellules mammifères et nous sommes fermement convaincus que
cette technique pourrait bénéficier à divers domaines tels que la recherche sur le développement
ou la recherche sur le cancer.
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La cellule est l’unité biologique structurelle et fonctionnelle fondamentale de tous les êtres vi-
vants. Chez l’homme, les cellules s’assemblent pour former des structures complexes telles que
des organes, des muscles ou des os. Bien que la plupart des cellules qui composent notre corps
possèdent exactement le même code génétique, chacune d’entre elles se différencie, entre autres,
par sa fonction. Cette diversité émerge d’une interprétation différente des changements envi-
ronnementaux. L’analyse de ces signaux se fait à l’intérieur de la cellule par un grand réseau
de protéines. Ce réseau s’apparente à un circuit électrique, où chaque interrupteur est relié à
un ou plusieurs autres interrupteurs. Au niveau cellulaire, à chaque interrupteur correspond
une protéine faisant circuler le signal dans une branche précise du réseau en contrôlant son état
“ON/OFF”. Suivant le type de chemin parcouru, le signal induira un type de réponse ou un autre.
Ce processus est communément appelé transduction du signal. Si la transduction du signal d’une
cellule était mesurée, sa voie de différenciation cellulaire serait anticipée. Cette thèse présente
une technique permettant de mesurer la transduction du signal dans des cellules vivantes et en
temps réel. La technique se base sur une protéine synthétique appelée SKARS qui va agir comme
une sonde pour l’activité d’un nœud du circuit de signalisation. Lorsque le nœud n’est pas actif,
la protéine est dans le noyau de la cellule et lorsque le nœud s’active, la protéine s’accumule en
dehors. Afin de visualiser ce processus, la sonde à été marquée avec une protéine fluorescente. En
utilisant un microscope à fluorescence, nous pouvons suivre la position de la sonde au cours du
temps et en déduire le degré d’activation du nœud mesuré. Nous avons appliqué cette méthode
dans l’étude du processus d’accouplement chez la levure Saccharomyces cerevisiae. Deux sondes
11
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ont été utilisées pour mesurer en parallèle l’activité du nœud de l’accouplement et du nœud
impliqué dans le déclenchement de la division cellulaire. Nos résultats montrent que la voie de
l’accouplement ne peut être activée qu’à condition que les cellules sentent de la phéromone et que
la voie de la division cellulaire soit éteinte. Par conséquent, la cellule ne peut choisir que l’une
de ces deux voies de différenciation. Grâce à cette méthode, nous avons aussi démontré que le
modèle décrivant le mécanisme d’inhibition croisé de ces deux voies était incomplet. En conclu-
sion, la sonde SKARS est outil extrêmement utile pour définir comment la cellule interprète les
signaux de l’environnement et ainsi comprendre pourquoi certaines voies de différenciation sont
choisies plus que d’autres. Cette sonde a été utilisée chez un organisme très simplifié, mais nous
sommes convaincus que cette technique permettra de répondre à d’importantes questions dans
les domaines de recherche sur le développement et sur le cancer.
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1. Introduction
Cell-Cell heterogeneity The cell is the smallest living entity which composes every organism.
Although cells from a pluri-cellular individual contain the same genetic code, they differ accord-
ing to several properties, which provide them various physiological functions. This led scientists
to classify cells in various cell types such as neuronal cells, blood cells, fibroblasts and other.
Interestingly, heterogeneity is also found among one particular cell-type. This can be an advant-
age, as for the B-lymphocytes that produce different types of antibodies, or a disadvantage, as
for cancer cell lines expressing different makers not necessarily targeted by drugs [1, 118].
Heterogeneity among a clonal cell population can be triggered by stochastic events. For ex-
ample, the DNA is known to be subjected to random modifications such as:
• single-nucleotide polymorphism (SNP) [63, 118]
• noisy gene expression [33, 98].
Those random modifications contribute to the evolution of species
Heterogeneity among a clonal cell population can also be triggered by deterministic events. .
Indeed, the cell probe and analyse changes occurring in the environment to adapt its physiology
state. The interpretation of extracellular cues can vary among a population leading to cell-to-
cell variability. Deterministic-related variability can be associated with the physical and chem-
ical properties of the environment (cell-cell contacts, growth factors) and influences many cell
physiological processes, such as proliferation, sensitivity to apoptosis, metabolic activity, cell
shape and motility [114, 2, 36]. Intra-cellular cues, such as the cell cycle position, also contrib-
ute to the emergence of heterogeneity. Studies in the budding yeast Saccharomyces cerevisae
have shown that activation of the mating process is only allowed in G1. Thus, the response to
pheromone will vary from one cell to another depending on their cell cycle position [81, 129].
To summarise, stochastic and deterministic events influence the behaviour of each individual
among a population. The fate choosen by a cell in defined by they interpret intra- and extracel-
lular cues.
22
MAPK pathways. Cell-to-cell heterogeneity emerges because each individual cell interprets
intra-/extracellular cues in a different way. Cue interpretation is carried on by a complex network
of proteins communicating with each other through post-translational modifications. This is
what is commonly called the signal transduction. The network composition and the relationship
between the nodes start to be well known for organisms commonly studied . However, it is still
challenging to correlate signal transduction with a particular cell fate, as it would mean to get
access to the activity state of all components of the signalling network simultaneously [114, 1].
Assays enabling to get such information can only acquired the physiological state of a whole
population and in one condition [78, 103]. Single cell analysis is thus required to analyse the
signal transduction and to correlate signalling activity patterns with a given cell-fate.
Since current dynamic single cell strategy does not enable to report the activity of the en-
tire signalling network, the solution consists on focusing on particular nodes with important
regulatory function [2, 62]. Mitogen activated protein kinases (MAPK) pathways are very well
conserved signalling cascades. In mammals, the three most studied MAPK are ERK, JNK and
p38, and regulate cell physiological processes, such as morphology, adaptation to stresses or cell
cycle progression. They are extensively studied for their implication into development, immune
response or cancer [89].
Such cascades transduces a signal coming from a receptor that senses environmental changes.
The information is then transmitted to the core of the signalling cascades composed of three
kinases, the mitogen activated protein kinase kinase kinase (MAP3K), the mitogen activated
protein kinase kinase (MAP2K) and the mitogen activated protein kinase (MAPK), which phos-
phorylate each other. Once the MAPK gets activated, this kinase up/down-regulates various
proteins to trigger a specific adaptation program [24, 89, 6, 96]. Some studies focusing on ERK,
p38 or JNK observed that these MAPKs exhibit numerous dynamic activity patterns that are
signatures of particular cell fate choices [95, 36, 2, 105]. For example, in normal rat epithelial
cells, ERK was shown to exhibit pulse activity that promotes entry into cell cycle. These pulses
disappear as cells touch each other and leads to the induction of a quiescent state [2].
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1. Introduction
MAPK pathways in Budding Yeast Saccharomyces cerevisiae is a prototypical eukaryote for
the study of signalling cascades. The four well-studied MAPK pathways of S.cerevisiae haploid
strains are the Cell Wall Integrity (CWI), the Hyper-Osmotic Glycerol (HOG), the Filamentous
Growth (FG) and the Pheromone Response (PR) or mating pathway (figure 1.1) [6, 16, 108,
107, 109] and are extremly well conserved among eukaryotes [130]. The CWI is homologous to
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Figure 1.1.: MAPK pathways in S. cerevisiae General scheme depicting the four MAPK path-
ways active in haploid budding yeast cells: the mating pathway, the filamentous
growth pathway, the Cell Wall Integrity (CWI) pathway and the High Osmolarity
Glycerol (HOG) pathway.
the JNK/P38 pathways. It is activated by cell-wall degradation, hypo-osmotic shocks or DNA
damages. It is composed of the Bck1 (MAP3K), Mkk1/2 (MAP2Ks) and the Mpk1 (MAPK),
which drive the adaptation through the regulation of cell wall synthesis [6, 16, 108, 107, 109].
The HOG pathway is also close to the p38 pathway and is induced upon hyper-osmotic shock.
It can be activated through two possible MAP3K branches, either the Ste11 or the Ssk2/22.
Both tracks lead to the activation of the MAP2K Pbs2, which then activates the MAPK Hog1
by phosphorylation [6, 16, 108, 107, 109]. The filamentous growth pathway is probably the less
understood MAPK signalling cascade. It shares homology with the mammalian ERK pathway
and gets activated by nutrient deprivation. It is composed of the MAP3K Ste11 that activates
the MAP2K Ste7, that subsequently activates the MAPK Kss1. Once active, Kss1 triggers cell
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filamentation and promotes invasive growth [6, 16, 108, 107, 109] . The last, but not least,
MAPK signalling cascade is the mating pathway. It shares homology with the ERK pathway
and controls the mating process between two haploid cells of opposite mating types. Activation
of this cascade starts from the sensing of exogenous pheromones, which leads to the recruitment
at the plasma membrane of a protein complex formed by the scaffold protein Ste5, the MAP3K
Ste11, the MAP2K Ste7 and the MAPK Fus3. A phosphorylation cascade occurs and leads to
the activation of the MAPKs Fus3 and Kss1 and induce the cell cycle arrest in G1. MAPKs
trigger also a transcriptional program and regulate proteins implicated in cell polarisation, cell
fusion and karyogamy [20, 44, 104, 7].
To sum up, MAPK pathways of S.cerevisiae are very well conserved and close to those of
the mammals [130]. Thus, this organism is a very good model to investigate signalling cascades
cross-regulation mechanisms.
The HOG pathway induces an homogeneous adaptation to stress. In budding yeast, most
of the MAPK pathways are implicated into the adaptation to stresses. . Hyper-osmotic shock
induces a rapid decrease of the cell volume. The process of adaptation starts by the activation of
the HOG pathway through the Ssk2/1 and the Ste11 tracks. Once the signal reaches Hog1, the
MAPK activates enzymes implicated in the glycerol production. Interestingly, phosphorylated
Hog1 is strongly imported into the nucleus to trigger a transcriptional program. The MAPK
then returns into the cytoplasm as cells recover their original size [37, 86, 74, 75].
The cell size recovery happens to be impressively homogeneous in the population. How can
this adaptation be so robust? First, the HOG pathway is identically activated in all cells. This
can be achieved by avoiding improper crosstalks with other signalling cascades through: specific
protein-protein interactions between components of the HOG pathway [41, 101, 108], the use
of scaffold proteins to recruit the required pool of signalling cascade components at the right
place [108, 6], direct inhibition of pathways that may interfere with osmotic shock response
[108, 112, 107, 82, 45]. Second, the HOG pathway blocks many dynamic processes, such as the
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cell cycle, that could be corrupted by the stress [18, 42]. Consequently, the HOG pathway exhibits
a uniform dynamic activity pattern, and triggers a homogeneous cell adaptation to stress.
The pheromone response is heterogeneous In contrast to the adaptation to hyper-osmotic
shock, cells respond differentially to the pheromone. Indeed, various cell shapes can be observed
when cells are exposed to intermediate concentrations of pheromone [4, 83]. Moreover, it was
reported that the pheromone response genes are induced with a dynamic that varies depending on
the cell cycle [129, 81]. This heterogeneity was described to be associated with a cross-inhibition
mechanism between the mating pathway and regulators of the cell cycle progression. The mating
regulates the cell cycle through the Fus3-dependent activation of the Far1. This cyclin kinase
inhibitor (CKI) inhibits the cyclin-dependent kinase Cdc28 by outcompeting with the cyclins
Cln1/2. This results in inhibition of the CDK and arrest of the cell cycle progression [91, 87].
On the other hand, it was reported that pheromone-response gene expression, such as FUS1,
occurs in G1 and not in S-phase. This suggests that the cell cycle regulates the mating. [81].
This inhibition mechanism driven by the cell-cycle requires the expression of the S-phase cyclins
Cln1, Cln2 and Cln3 (CLN) and occurs through the regulation of the Far1 CKI and the Ste5
scafold prtein. When CLN start to be expressed at the interplay between G1- and S-phase,
Far1 is thought to be degraded avoiding mating-induced cell-cycle arrest [72, 80]. In parallel,
CLN induce the detachment of the Ste5 from membrane by promoting the phosphorylation of
a membrane binding domain of the scaffold protein by Cdc28 and leading to reduced signalling
through the mating pathway [93, 116].
To sum up, cells are not permissive to mating in all phases of the cell cycle. This explains why
the response to pheromone is heterogeneous. This heterogeneous pheromone response imposes
some technical limitations in the study of the cell cycle and mating cross-inhibition. The current
strategies used to counteract these problems are either to synchronise cells in a particular cell
cycle phase using chemicals (or thermosensitive mutants[80, 53]), or to overexpress one regulator
of the cell cycle, usually cyclins (CLN) [129, 116]. These are very artificial conditions that illus-
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trate the requirement of new live single cell-based techniques that report on signalling cascades
activity without affecting the cell fitness.
Dynamic kinase activity measurements at the single cell level Variability in the cell behaviour
is often associated with specific dynamic signalling cascade activity patterns. Such patterns
emphasise the processing of the signalling cascade inputs For example, pulsed activation of the
mammalian MAPK Erk induces proliferation while sustained activity is thought to promote cell
differenciation [95, 2]. Thus, to comprehend how a cell undergoes a given fate, the signalling
cascade activity must be dynamically visualised in living single cells. In addition, to confirm the
relevancy of an observed pattern, these measurements must be performed on hundreds of cells.
Some groups succeeded in observing the dynamic activity of MAPKs using Western Blot.
However, they only extract whole population information and therefore cannot judge whether
the observed activity pattern corresponds to the dynamic kinase activity of the single cells [54,
43, 77, 136]. This can be solved using fluorescent protein-based transcriptional or translational
reporters [84, 102, 83]. Although transcriptional reporters are good in steady state conditions, the
dynamic of the output signal does not necessarily reflect the dynamic activation of the upstream
signalling cascade. This is mostly because transcription is a slow process compared to signal
transduction and because fluorescent proteins require a maturation time [3, 86, 103].
Kinase activity can, in some cases, be translated in a subcellular localisation change. Some
proteins, such as the NFκB transcription factor in mammals or the MAPK Hog1 and the tran-
scription factor Whi5 in yeast, enter or exit the nucleus after being phosphorylated [37, 86, 74,
75, 21, 29, 28]. This is an interesting property, as the relocation from/to the nucleus occurs with
a rate closer to signal transduction than transcription. Unfortunately, not all kinases or their
substrates exhibit such a behaviour. This limits us in the capacity to report the activity of a
specific node in the signalling cascade network [133].
10 years ago, brand new synthetic biology techniques appeared. The most relevant example is
a technique which combines a synthetic fluorescence resonance energy transfert (FRET)-based
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kinase sensor with time lapse fluorescent microscopy and automated image analysis [124, 51,
39, 38, 2]. This system showed its potential in the context of the study of the ERK dynamic
activation [2] but also in studies focusing on Fus3 and Kss1 [19]. However, this FRET sensor
limits the capacity to report on various pathway activity states at the same time, because multiple
fluorescent channels are used by one reporter. Moreover, multiple rounds of optimisation are often
required to reach the best signal-to-noise ratio for one particular target [124, 62, 19].
To sum up, various cell fates are observed among a population, because cells adjust their
adaptation process to environmental changes with their current physiological state. Intra- and
extraellular cues are processed by signalling cascades that cross-regulate each others. In order to
define the cross-regulation mechanisms between signalling pathways, the activity state of multiple
signalling cascades must be analysed in live single cells. However, current methods do not enable
to perform such measurements.
The first chapter of this thesis describes a new approach combining synthetic biology, fluor-
escent microscopy and automated image analysis. The system we engineered enables kinase
activity measurement, dynamically and in hundreds of living cells [85, 30]. We also show that
our technique is very specific to the target, can be easily adapted to report the activity of various
kinases and is compatible with other fluorescent based techniques. The second chapter of this
thesis describes how we applied this technique in the context of the study of the cross-inhibition
mechanism between the mating pathway and the cell cycle in S.cerevisiae.
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2. Dynamic single cell measurements of
yeast MAPK activity by synthetic kinase
activity relocation sensor.1
1All the Data presented in this chapter were published in 2015 in the BMC biology journal (See Durandau &
al. [30]). The article is in open access http://www.biomedcentral.com/1741-7007/13/55
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2.1. Background
Signal transduction is an essential part of cellular life. Cells perceive changes in their environ-
ment and integrate these extra-cellular signals with intra-cellular cues to mount an appropriate
response. This is achieved by signal transduction cascades, where receptors at the plasma mem-
brane sense the surrounding medium and transmit this information to intracellular enzymes
that modulate the activity of other proteins to induce a specific response via post-translational
modifications .
The Mitogen Activated Protein Kinase (MAPK) pathways are a conserved family of signalling
cascades which respond to a wide range of signals, such as growth hormones, nutrient status or
stresses [96]. These pathways are activated by surface sensors (often G-protein coupled receptors),
which transduce their information via membrane-associated proteins to the highest member of the
MAPK cascade, the MAP kinase kinase kinase (MAP3K). In turn, the MAP3K phosphorylates
the MAP kinase kinase (MAP2K), which finally doubly phosphorylates the MAPK to activate
it. MAPKs have a large range of substrates both in the cytoplasm and in the nucleus where they
actively promote the transcription of new genes. Although these pathways are often viewed as
linear signalling routes where a given output elicits a specific response, they actually are part of
a complex signalling network where cross-activation and cross-inhibition mechanisms are readily
found.
In the model organism Saccharomyces cerevisiae, four MAPK pathways are active in haploid
cells: the mating pathway, the filamentous growth pathway, the High Osmolarity Glycerol (HOG)
pathway and the Cell Wall Integrity (CWI) pathway [107] (figure 2.1). The mating pathway is
activated in haploid cells in response to pheromones (a- or α-factor). In MATa cells, α-factor
is sensed by the G-protein coupled receptor Ste2. The binding of the ligand results in the
dissociation of the trimeric G-protein. Free Gβγ recruits the scaffold protein Ste5 to the plasma
membrane, which promotes the activation of the MAP3K Ste11, which in turn activates the
MAP2K Ste7. This kinase further activates two MAPKs Fus3 and Kss1 which both contribute
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Figure 2.1.: MAPK pathways in S. cerevisiae General scheme depicting the four MAPK path-
ways active in haploid budding yeast cells: the mating pathway, the filamentous
growth pathway, the Cell Wall Integrity (CWI) pathway and the High Osmolarity
Glycerol (HOG) pathway.
to the mating response [68, 7].
While this pathway is a prototypical example of a growth response pathway, the CWI is more
akin to a stress response cascade. Cell wall remodeling is constantly taking place during growth
of the yeast. In addition, the CWI pathway is also acutely activated by environmental stresses
such as heat, hypo-osmotic stress, or cell wall damaging agents [68]. The sensing mechanism of
these stresses is not fully understood, it is nevertheless clear that they act via MAP3K Bck1,
which activates the MAP2Ks Mkk1 and Mkk2, both of which phosphorylate the MAPK Mpk1
(Slt2). Mid2 and Wsc1 have been identified as the most important sensors for this pathway and
transduce their status via Rho1 and Pkc1 to the MAPK cascade [68]; however, other stimuli take
alternative routes. As an example, zymolyase (which consists of a cocktail of enzymes degrading
the cell wall) activates the HOG pathway and, subsequently, its MAPK Hog1 activates Pkc1 via
an unknown mechanism[10].
Despite its apparent simplicity, the budding yeast MAPK network shares multiple common
features with its counterparts in higher eukaryotes, such as MAP3K or MAP2K, which can acti-
vate multiple downstream MAPKs depending on the stimulus. Extensive experimental evidence
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has demonstrated that these [108, 5]. Thus, they can regulate cell cycle progression, metabolism,
or stress response, or in other instances be regulated by these same processes. The integration of
these signals can lead to a variability in the response of individual cells to a given stimulus be-
cause the physiological state of each individual cells can vary [36, 83, 124, 94]. Thus, dynamic and
quantitative single cell measurements are required to untangle the complex regulatory network
that controls the activity of MAPKs in a cell.
Therefore, we set out to design synthetic substrates for MAPKs that would relocate between
the cytoplasm and the nucleus upon phosphorylation. These synthetic kinase activity relocation
sensors (SKARS) were designed with a modular architecture based on three parts: a docking site
offering specificity for the kinase of interest, a nuclear localization sequence that is inactivated
by phosphorylation, and a fluorescent protein that reports on the nuclear-to-cytoplasm shuttling
of the sensor. Herein, we demonstrate the modularity of this strategy by engineering sensors
for the mating pathway MAPKs Fus3 and Kss1 as well as for the CWI MAPK Mpk1. These
sensors allowed measurement of the dynamics of MAPK activation in single cells. We could
identify a heterogeneity in the response of the cells upon α-factor or zymolyase treatments which
demonstrates the ability of the MAPK signalling pathways to integrate intra-cellular cues to
tune the response delivered by the MAPK.
2.2. Results
2.2.1. Sensor design
Nuclear localization sequences (NLSs) consist of a stretch of positively charged residues associated
with importin, which will subsequently shuttle its cargo into the nucleus [56]. Harreman & al.
[49] demonstrated that additional negative charges around the NLS compromise its binding
to importin and thereby decrease the enrichment of the cargo in the nucleus. Further, they
observed that the NLS for the Swi6 transcription cofactor was led by a serine, which is a potential
phosphorylation target. Indeed, mutation of this residue to an alanine resulted in a constitutively
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Figure 2.2.: Schematic of the three domains of the SKARS sensor. The docking site (DS), the
nuclear localization signal (NLS), and the fluorescent protein (FP). The Ste7DS-
NLS-RFP SKARS is composed of the Ste7 docking site (Ste7DS , amino-acids 1-33),
a double NLS, and the mCherry protein
nuclear Swi6 protein. Based on these findings, we used the Swi6 NLS as a phosphorylation target
for our sensor, with the idea that phosphorylation would lead to an exit of the sensor from the
nucleus. To increase the efficiency of relocation, we added a second phosphorylation site after
the positive stretch of amino-acids and combined two such NLSs in our sensor (figure 2.2).
Figure 2.3.: Microscopy images of cells before and after stimulation with α-factor. In the red
channel, one can observe the nuclear exit of the sensor after stimulus while the
CFP-histone tag signal remains stable.
All MAPKs share the same consensus phosphorylation motif SP or TP. Specificity is achieved
via an interaction surface in the kinase called the docking groove. This motif associates with
a docking site (DS) with the consensus motif (R/K) 1-2-X4-6-LXL, which has been identified
on MAPK substrates as well as on MAPK phosphatases and up-stream activators (MAP2K)
[120, 121]. These interaction motifs are present throughout eukaryotes from yeast to mammals.
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Exchange of this DS has been shown to dictate specificity towards a substrate or, in the case
of a MAP2K, control the specificity of the activated MAPK [135, 101]. The group of Wendell
Figure 2.4.: Image segmentation process. A, B and C. Three pictures are used for image segmen-
tation: CFP: Hta2-CFP nuclear tag (A), BF0: in-focus brightfield image (B), BF1:
slightly out of focus brightfield image (C). D, E and F. Based on these pictures,
three objects are defined in the image. First, the Nucleus object is segmented based
on the CFP intensity (D, blue). Then, using the two brightfield images, the contour
of the cell is defined allowing to identify the Cell object (E, green). Finally, by
subtracting the Nucleus object enlarged by 2 pixels from the Cell object, we define
the Cytoplasm object (F, red).
Lim has characterized various DSs that interact with Fus3 and Kss1 [101]. We used the first
33 amino acids of Ste7, which contains the DS with the strongest affinity towards Fus3 and
Kss1. The Ste7DS and double-NLS construct was fused to mCherry (figure 2.2). As shown
in figure 2.3, the sensor is enriched in the nucleus under vegetative growth conditions. Upon
stimulation of the cells with α-factor, the fluorescent protein quickly relocates to the cytoplasm.
Automated segmentation of the images allows the identification of the nucleus and cytoplasm
for each cell (figure 2.4) [85]. The ratio of the average intensities in the nucleus and in the
cytoplasm is calculated as a function of time for each cell. The median, 25-, and 75-percentiles of
the population are plotted for cells treated with 1 μM α-factor or unstimulated cells (figure 2.5.A).
At the onset of the experiment, the ratio is high, denoting an enrichment of the sensor in the
nucleus. Upon α-factor addition, this ratio drops within a few minutes. This result suggests that
the sensor is phosphorylated by Fus3 and/or Kss1 in response to α-factor treatment, leading to
its relocation from the nucleus to the cytoplasm.
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Figure 2.5.: Response of cells bearing the functional sensor and stimulated with 1 μM α-factor
(Nc = 170) is compared to cells deficient for signal transduction (ste11Δ, Nc = 360,
A), cells bearing a non-docking variant of the sensor (Ste7 ND , Nc = 300, B), or
a non-phosphorylatable (NLS-4A, Nc = 360, C) or phospho-mimicking variant of
the sensor (NLS-4E, Nc = 750, D). Unitless measurements, such as the Nucl/Cyto
ratio, are denoted by the symbol [–] in the axis legend. For all similar graphs and
unless stated otherwise, the solid lines represent the median of the cell population
and the shaded area the 25 and 75 percentile of the population. Nc represents the
number of single cells measured
To demonstrate the specificity of this response, we repeated this experiment in cells deficient
for MAPK activation (ste11Δ), in which the sensor remained enriched in the nucleus upon
stimulation (figure 2.5.B). We can further demonstrate that this response depends on an intact
DS. Indeed, mutation of the DS of Ste7 abolishes the response (figure 2.5.C). Moreover, mutation
of the four serines in the two NLSs to phospho-mimicking residues (glutamic acid:NLS-4E) or
to non-phosphorylatable residues (alanine: NLS-4A) alters the localization of the fluorescent
protein in the cell, but neither of these constructs display a change in nuclear-to-cytoplasmic
partitioning upon pheromone stimulation (figure 2.5.D).
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Figure 2.6.: Inhibition of the MAPK Fus3 prevents the relocation of the sensor. fus3Δkss1Δ cells
bearing the Ste7DS -NLS-RFP SKARS and an integrated fus3-as were stimulated
with pheromone in presence or absence of the inhibitor NAPP1. A.NAPP1 or DMSO
were added 8 minutes prior to the addition of α-factor. The median nuclear-to-
cytoplasmic ratio is plotted as function of time (NAPP1: Nc = 343, DMSO: Nc =
230). B. Ten minutes after α-factor stimulation, cells were treated with NAPP1 or
DMSO. Note that, upon inhibition of Fus3-as, the sensor returns within 7 minutes
to its basal nuclear enrichment level (NAPP1: Nc = 177, DMSO: Nc = 123)
Finally, we also verified that the direct inhibition of the MAPK using an analog-sensitive allele
blocked the phosphorylation and hence the relocation of the SKARS (fus3-as in fus3Δkss1Δ,
figure 2.6.A) [15]. Interestingly, addition of the inhibitor after the activation of the pathway leads
to a rapid return of the sensor to its basal nuclear enrichment level, underlying the dynamic nature
of the bio-sensor phosphorylation (figure 2.6.B). Taken together, these results clearly demonstrate
that we have generated a specific sensor for mating MAPK activity.. The relocation is dependent
on an active kinase that binds to the sensor via the specific DS and phosphorylates the serines
in the NLSs. This modification is reversible, allowing for a dynamic measurement of the MAPK
activity.
To assess if the presence of the SKARS perturbs the mating response of the cells, we confirmed
that cells could arrest their cell cycle and form mating projections (figure 2.7.A and B). These
qualitative tests revealed no difference between cells bearing docking or non-docking versions of
the sensor. However, we noted a minor difference in the transcriptional response of cells due
36
2.2. Results
Figure 2.7.: Effect of the sensor on polarisation and pheromone dependent cell cycle arrest.
A. Cells bearing the Ste7DS-NLS-RFP sensor are able to form a mating projection
upon α-factor stimulation. B. The ability of cell to arrest their cell cycle upon
pheromone treatment was observed by halo assay. WT, Ste7DS-NLS-RFP, Ste7ND-
NLS-RFP and Ste7DS-NLS-RFP in ste11Δ cells were platedon rich medium. Cells
were sowed with beads on a plate and 10µl of α-factor 1mg/ml was added on a
filter disk. The absence of cell growth around the filter is indicative of the cell cycle
arrest. The comparable size of the halo between cells bearing a functional sensor, a
non-functional sensor or no sensor indicates an equivalent sensitivity to pheromone.
to the presence of the sensor by quantifying by flow cytometry the expression of the PFIG1-
quadrupleVenus expression reporter [86] (figure 2.8). This slight increase in expression could
potentially be explained by a minor enrichment of the MAPKs in the nucleus induced by the
presence of the sensor.
2.2.2. Inferring MAPK activity
To extract MAPK activity from sensor relocation measurements, we have developed a simple
mathematical model describing the relationship between the relative concentration of the sensor
in the nucleus and in the cytoplasm and the activity of the MAPK (See AppendixB for description
of reactions and parameters). Figure 2.9 is a scheme of the various reactions included in the
model . A MAPK and a phosphatase regulate the level of phosphorylation of the sensor. The
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Figure 2.8.: Cells bearing an expression reporter pFIG1-qVenus where transformed with a func-
tional (Ste7DS-NLS-RFP) or non-functional (Ste7ND-NLS-RFP) sensor. Cells were
stimulated with a range of α-factor concentrations. 1.5 hours after stimulation they
were treated with cycloheximide (0.1 mg/ml) and 1.5 hour later measured by flow
cytometry. A minor increase in fluorescence level in cells bearing the functional
sensor indicates a slight increase in expression ability of these cells.
action of the phosphatase is constitutive. The concentration of MAPK in the cell is constant;
however, the ratio of active MAPK (MAPK activity defined as the fraction of the total MAPK
pool in the active state) changes as a function of time. For simplicity, we consider that these
reactions occur with similar rate constants in the nucleus and in the cytoplasm. The sensor can
freely diffuse between the nucleus and the cytoplasm (k Diff ), but only the unphosphorylated
SKARS is actively imported in the nucleus (k Imp). The model can be forward-simulated by
generating a specific time-course of MAPK activity (figure 2.10.A) and calculating the resulting
nuclear-to-cytoplasmic partitioning of the sensor (figure 2.10.B). At steady-state, there is a close
to linear relationship between the MAPK activity and the nuclear-to-cytoplasmic ratio of the
sensor (figure 2.10.C).
We can also use the model to estimate MAPK activity based on a measured nuclear-to-
cytoplasmic ratio. We quantified the steady-state nuclear enrichment of the sensor in a pop-
ulation of cells 15 minutes after induction with various concentrations of α-factor (figure 2.11.A).
Based on these data, we can obtain the dose-response curve of MAPK activity, which extends
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Figure 2.9.: Scheme of the reaction implemented by the model.. Schematic of the reactions
implemented in the model. The SKARS is phosphorylated in the nucleus and in
the cytoplasm by MAPK and dephosphorylated by phosphatase. The exchange of
SKARS between the cytoplasm and the nucleus can occur through passive diffusion,
while only the unphosphorylated SKARS is actively imported in the nucleus.
from 0.2 for an unstimulated sample to 1 for saturating levels of pheromone (1 μM). A MAPK ac-
tivity of 1 implies that both Fus3 and Kss1 are completely phosphorylated in saturating levels of
pheromone. While this level might seem high, a recent study on the HOG pathway suggests that
close to 100 % of MAPK Hog1 is phosphorylated upon hyper-osmotic shock [34]. A non-docking
mutant is used as reference and displays no MAPK activity. It has been shown that HOG and
the mating pathways have some basal level of MAPK activity under normal growth conditions
[71]. The exact level of this basal signal is difficult to estimate, but we consistently observe an
increase in nuclear enrichment of the sensor in signalling dead cells as well as in non-docking
versions of the sensor (figure 2.5.B and .C).
Using a similar strategy, the dynamics of MAPK activity can be estimated from time-course
measurements of sensor relocation. As a proof of concept, we use the activation and inhibition
of the pathway by α-factor and subsequent inhibitor addition presented in figure 2.6.B. Before
stimulus, the MAPK activity was low. Upon α-factor addition, it reached 0.8 in less than
3 minutes after stimulus. Upon inhibition, MAPK activity dropped at a much slower rate.
This decay is controlled by multiple factors such as the time of entry of the drug in the cell,
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Figure 2.10.: Simulated nuclear to cytoplasm ratio from MAPK activity. A. Time-course of
MAPK activity is calculated for different final levels of MAPK activity and used
as inputs into the model. B. The resulting nuclear- to-cytoplasmic partitioning of
the sensor for these different MAPK activity traces are obtained as output. C.
Correlation between MAPK activity and the nuclear-to-cytoplasmic ratio at the
end of the simulation.
the dephosphorylation of the bio-sensor, and its exit by diffusion out of the nucleus. This
mathematical model demonstrates that there is a tight relationship between SKARS localization
and MAPK activity and that, using a few simple assumptions, it is possible to extract the mean
MAPK activity of the population from the experimental measurements.
2.2.3. Single cell measurements
While a clear exit of the sensor out of the nucleus can be measured at the population level,
we next wanted to verify whether we could also obtain kinase activity measurements at the
single cell level. We noticed that there is a large variability in the nuclear enrichment of the
sensor between individual cells prior to induction (figure 2.12.A). This large difference could
arise from varying basal activity of the pathway [71] or from an intrinsic ability of a given cell
to accumulate the sensor in the nucleus. To differentiate between these two possibilities, we
combined a functional (Ste7DS -NLS-YFP) and a non-functional sensor (Ste7ND -NLS-RFP) in
the same cell. We define the Basal Level as the nuclear-to-cytoplasmic ratio of the SKARS before
induction ( figure 2.12.A). Using this measurement, we observe a high correlation between the
nuclear enrichment of the two sensors within a cell, which demonstrates that each cell has an
inherent ability to import the sensor (figure 2.12.B). Evidently, in cells displaying a higher nuclear
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Figure 2.11.: Simulated MAPK activity at various pheromone concentrations and prior and after
Fus3-as inhibition. A. Dose-response curve of the nuclear enrichment of the sensor
as a function of concentration after 15 minutes of stimulation with pheromone (blue
circles). The mean and standard deviation of three measurements are plotted.
The corresponding MAPK activity level is calculated (red circles). As reference,
the nuclear-to-cytoplasmic ratio of the unstimulated non-docking sensor and its
corresponding level of MAPK activity are indicated by blue and red squares. B.
Determination of MAPK activity for the experiment from figure 2.6.B. The blue
circles correspond to the experimental data points. The dashed blue line represents
the fit of those points by the model. The solid red line is the extrapolated MAPK
activity for this time-course
enrichment of the sensor, the change in nuclear-to-cytoplasmic ratio upon stimulation is easier
to quantify ( figure 2.12.A). To allow for a fair comparison between each individual single cell
trace, they were normalized by their basal levels. For each individual trace, the initial response
(3 to 5 minutes after stimulus) and the final response (last three points of the time-lapse) were
quantified (figure 2.13.A-D).
The normalized nuclear-to-cytoplasmic ratios of roughly 300 single cells were sorted based on
their final responses and displayed in a heat map where each line corresponds to a single cell
trace (figure 2.14.A). In the lower part of the map, cells displaying a large change in nuclear-to-
cytoplasmic enrichment upon stimulation are clustered (high final response). The upper part of
the map represents a fraction of the population where no response is detected. To discriminate the
responding cells from the non-responding ones figure 2.14, we compared the single cell responses of
two strains bearing either the docking or the non-docking sensor (Ste7DS-NLS-RFP and Ste7ND-
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Figure 2.12.: Variability of the basal ratio N/C from cell-to-cell. A. Nucleus to Cytoplasm ratio
for three single cell traces. The mean value of the three first points allows to define
the Basal Level of the trace (Nucl/Cyto(t=-4:-2min)). B. Correlation between
the Basal Level measured in the YFP and RFP channels of a strain bearing two
sensors, one with a functional docking sequence (Ste7DS-NLS-YFP) and one with
a non-docking variant (Ste7ND-NLS-RFP). The high degree of correlation between
the two measurements demonstrates that the Basal Level of the sensor is mostly
dependent on the intrinsic property of the cells to enrich the sensor and does not
depend on a variable constitutive activity of the mating pathway.
NLS-RFP, respectively).Using the non-functional sensor as a reference, we set a threshold to
discriminate between the responding cells and non-responding cells bearing the functional sensor
(2.15). Roughly 17% of the cells measured were thus characterized as non-responding (2.14.B).
In the group of responding cells, we could also differentiate two types of responses. A small
fraction (11 %) of the total cell population displayed a delayed response, characterized by an
initial response weaker than the final response (arbitrarily defined as more than a 50 %-fold
difference, 2.14.B). 2.14.C represents the mean response of the cells in the defined categories
(solid lines) as well as the response of one cell from each sub-population (dotted line), identified
by a circle in panel B. Images of these same cells are also provided in panels D, E, and F. The
heterogeneity in the dynamics of SKARS between these three populations of cells suggests that
they have very different levels of MAPK activity, which may be linked to an intrinsic difference
in their ability to respond to mating pheromone.
It is indeed well-established that the signalling activity in the mating pathway is dependent on
the cell cycle stage [81, 116]. Cells which are committed to division and have entered the S-phase
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Figure 2.13.: Initial and final response define the dynamic relocation of the sensor at the single
cell level. A. Single cell traces are normalized by their Basal Level to allow for
a better comparison between individual cell responses. The normalized traces of
the three same cells from figure 2.12.A are shown in panel A. The Final Response
is calculated as (NuclCyto t=−4:−2min −
Nucl
Cyto t=12:15min
)/NuclCyto t=−4:−2min. The Initial Re-
sponse is calculated as (NuclCyto t=−4:−2min −
Nucl
Cyto t=4:6min
)/NuclCyto t=−4:−2min. B and C.
Correlation between the Basal Level and the difference in Nucleus to Cytoplasm
ratio NuclCyto t=−4:−2min −
Nucl
Cyto t=12:15min
. (B) or Basal Level and the Final response
(C). The strong bias for the difference in Nuclear/Cytoplasmic ratio as function of
Basal Level is corrected by the normalization applied in panel C. Open circles are
classified as non-responding cells.
become refractory to signal transduction. To correlate cell cycle stage with the dynamics of the
SKARS, we tagged Whi5 and Yox1 with mCitrine in cells bearing the sensor. Whi5 is a repressor
of G1 transcription and accumulates in the nucleus of the cells during G1 (figure 2.16.A). It has
been used previously as a marker for G1-entry and exit [9]. Yox1 is a transcription repressor
that inhibits the expression of cell cycle regulated genes induced in the M and G1 phases [92]. It
enters the nucleus upon S-phase entry and remains there until the beginning of G2 (figure 2.16.B).
As expected, cells with nuclear Whi5 were predominantly responding (figure 2.17.A, dark blue
dots). In contrast, a large fraction of the Yox1 positive cells were non-responding (figure 2.17.B,
light blue dots). Cells with cytoplasmic Whi5 were equally split between non-responding and
responding cells. Based on the Yox1 data, we can assume that these non-responding cells are
mainly S-phase cells (figure 2.17.A, light green dots) and, therefore, the responding ones are
G2/M cells (figure 2.17.A, dark green dots). Similarly, we can assume that the Yox1 negative
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Figure 2.14.: Single cell analysis of MAPK activity upon pheromone stimulation. A Heat map of
the response of individual cells to 1 μM α-factor. Each line represents the nuclear-
to-cytoplasmic ratio of one single cell normalized by its basal level (Nc = 293).
The cell responses were sorted based on the level of final response (measured at T
= 12 min). The cells were classified as responding (cyan), non-responding (green),
or slow responding (blue). The basal level of each trace is indicated in shades of
red (from black to red, increasing basal level). B Scatter plot of initial and final
response of the cells. Each dot corresponds to a single cell measurement. The colour
indicates to which sub-population the cells belong to. C Temporal evolution of the
nuclear-to-cytoplasmic ratio upon pheromone treatment. The solid line represents
the mean response of each sub-population. The dashed lines are traces from the
three single cells circled in panel (B). D, E, F Images of the selected cells in the
brightfield, CFP (histone tag), and RFP (Ste7DS -NLS-RFP) channels at different
time points. The dark line in the brightfield image represents the segmented cell
contour
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Figure 2.15.: Quantification of single cell response. A. Histogram of the Final Response measured
in a population of cells bearing the functional sensor (Ste7DS -NLS-RFP, red) and
the non-functional sensor (non-docking, Ste7ND -NLS-RFP, blue). The histogram
of the final response in the population allows to set a threshold (dashed line) at
0.2 to minimize the number of cells bearing the non-functional sensor considered
as responding. B and C. Correlation between Basal Level and Final Response (B),
and Final Response and Initial Response (C) for docking (red) and non-docking
(blue) versions of the sensor. The filled circles represent the responding cells. 82%
of the cells bearing the functional sensor are characterized as responding. These
graphs demonstrate that the difference between a functional and non-functional
sensor can also be observed at the single cell level
population, which displays a response, is dominated by G1 cells (figure 2.17.B, dark green dots),
while responding cells with a Yox1-positive signal must be in the G2 phase (figure 2.17.B, dark
blue dots). Note also that the various population identified using the Whi5 or the Yox1 marker
exhibits different MAPK activity level prior stimulation. This values turn to be high for cell in G1
and low for cells in S-G2-M phases. This would suggest that the MAPK activity is differentially
regulated depending on the cell-cycle. This result will be further discussed in chapter 3, 3.2.1.
Taken together, these results are in general agreement to what was previously known: G1,
M, and G2 cells are permissive to α-factor signalling while S-phase cells are refractory to this
stimulus. However, these data also offer some additional insights about this regulation. First of
all, there is a clear kinetic difference in the activation of the sensor between G1 cells and G2/M
cells. In G1 cells, the sensor exits the nucleus within 3 to 4 minutes after the stimulus, while the
G2/M cells seem to display a slower response (figure 2.17.C, dark blue vs. dark green curves).
45
2. Dynamic single cell measurements of MAPK activity
B -1 4 10 minA
BF
Ht
a2
-C
FP
St
e7
DS
-N
LS
-R
FP
Yo
x1
-m
Ci
tri
ne
BF
Ht
a2
-C
FP
St
e7
DS
-N
LS
-R
FP
W
hi5
-m
Ci
tri
ne
-1 4 10 min
Figure 2.16.: Subcellular localization of the Whi5 and Yox1 cell cycle marker. Yeast cells ex-
pressing the Ste7DS-NLS-RFP sensor and Whi5 tagged with mCitrine (A) or Yox1
tagged with mCitrine (B) imaged before and after stimulation with α-factor.
This sub-population of cells is clearly enriched for slow responding cells (figure 2.14.B dark blue
dots and figure 2.18.A red dots). This suggests that Fus3/Kss1 activity in this phase of the cell
cycle is reduced. The second interesting observation is the fact that almost all sub-populations
display an early exit of the sensor, which subsequently returns to basal value for non-responding
cells (figure 2.17.C, light green curve and figure 2.17.D light blue curve). This hints at a transient
activation of the pathway at early time-points, which cannot be sustained if the cells are not in
the proper cell cycle stage.
2.2.4. Combination of sensors
In the previous experiment, SKARS were associated with fluorescently tagged proteins to cor-
relate kinase activity and cell cycle stage. In a similar manner, we can envision to combine
multiple SKARSs in the same cell to correlate the activity of different kinases. Indeed, the flu-
orescent protein in the sensor is an inert bystander of the relocation process and its exchange
should not affect the response of the sensor. To verify this statement, we combined an RFP and
a YFP versions of the sensor (Ste7DS -NLS-RFP and Ste7DS -NLS-YFP) in the same strain.
While there is a slight difference between the YFP and RFP ratio measured with the sensor, the
dynamics of the response measured with both sensors are strikingly similar (figure 2.19.A). At
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Figure 2.17.: Cell cycle dependent dynamics of signalling in the mating pathway. A, B Correla-
tion between the measured Whi5 (Nc = 616, A) and Yox1 (Nc = 698, B) nuclear
enrichment (nuclear – cytoplasmic intensities) measured before stimulation and the
sensor’s final response. The scatter plot is split in four quadrants. The blue dots
represent cells with an enriched nuclear marker, while the green dots represent cells
where no enrichment is detected. The dark and light coloured dots represent, re-
spectively, responding and non-responding cells. C, D Average response of the four
sub-populations of cells in the four quadrants delimited on panels c (Whi5, C) and
d (Yox1, D). The colour code is the same as in (A) and (B).
the single cell level, we measured a high correlation between the final responses measured with
each sensor (figure 2.19.B). The Ste7DS allows the sensing of the combined activity of Fus3 and
Kss1. In their analysis of MAPKs’ DSs, Lim & al. [101] revealed the difference in structure
between the DS of Ste7, which binds both Fus3 and Kss1, and the DS of Far1, that is specific
for Fus3. The presence of two prolines in the Far1DS forces the binding to MAPK via a different
conformation that is not compatible with the Kss1 docking groove. To test whether we could
confer Fus3 specificity to our sensor, we replaced the 11 amino acids in the Ste7DS by the 13
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Figure 2.18.: Slow responding cell in G2/M cell cycle stage. A. Same panel as in Figure 5C
displaying the Whi5 Nuclear enrichment vs. Final Response of the cell. Cells
displaying a slow response are marked with a red dot. 33% of the G2/M cells
are characterized as slow responding (only 5% in the G1 cells population). 76%
of the slow responding cells are found in the G2/M quadrant. B. Dynamics of
Nuclear exit of the SKARS. Blue: average response of G1 Cells. Green: average
response of G2/M cells. Yellow: average response of the fast responding cells in
G2/M stage. Red: average response of slow responding cells in G2/M stage. C.
and D. Histograms of the Initial and Final Response of the four sub-population of
cells selected in panel A. The histogram of the slow responding cells (dark green)
is the only one that shifts considerably between the initial and final response. E.
Comparison of Initial and Final Response histograms for G2/M (green) and G1
(blue) cells. Note the shoulder in the histogram (arrow) denoting a population of
cells that have not responded within the first 5 min of the time-lapse but which
has disappeared in the Final Response histogram. F. Comparison of Initial and
Final Response histograms for G2/M cell with slow (red) or fast (yellow) response
phenotype. The slow responding cell display a clear shift in the histogram between
Initial and Final Responses.48
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Figure 2.19.: Generation of a Fus3-specific sensor based on the Far1 docking site. A. Combination
in the same cell of two sensors bearing the same Ste7DS but tagged with mCherry or
mCitrine and stimulated at time 0 with 1 μM α-factor (Nc = 660). The ratios were
plotted on two different y-axes (left: Ste7DS-NLS-YFP, right: Ste7DS-NLS-RFP)
to allow a direct comparison of the dynamic response of both sensors. B. Correlation
of the Final Response in cells bearing the Ste7DS-NLS-YFP and Ste7DS-NLS-RFP
sensors.
residues forming the Far1DS (figure 2.20.A). To test the specificity of this sensor, we combined
the Far1DS-NLS-RFP and Ste7DS-NLS-YFP sensors in the same cells and quantified their re-
sponses in wild-type (WT) and MAPK deleted strains (figure 2.20.B-C). Both sensors relocate
in WT and kss1Δ backgrounds. As expected, all relocation is abolished in the double MAPK
deleted fus3Δkss1Δ strain. Interestingly, in fus3Δ cells, only the Ste7DS-NLS-YFP sensor exits
the nucleus upon α-factor stimulation, demonstrating the specificity of the Far1DS for phospho-
rylation by the Fus3 MAPK. The histogram of the final response measured in individual cells
is displayed in figure 2.20.C. In fus3Δ cells, a weak but statistically significant activation of the
pathway can be detected. Note also that the basal nuclear enrichment of the Ste7DS-NLS-YFP
sensor in this strain is lower, which suggests that, in the absence of Fus3, there is a slightly
higher level of MAPK Kss1 activity. This is in agreement with previous observations showing
that Kss1 is overexpressed and displays a higher basal activity in a fus3Δ background [47]. It
is noteworthy to mention that both the dynamics and level of kinase activity in WT and kss1Δ
cells are very similar, arguing for a predominant contribution of Fus3 to the response of the cells
when stimulated with 1 μM α-factor.
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Figure 2.20.: A. Engineering of a Fus3-specific sensor by replacing the Ste7 docking site with the
Far1 docking site sequence (Far1DS). B. Response of cells of different background
(WT (blue, Nc = 630), fus3Δ (green, Nc = 474), kss1Δ (red, Nc = 990), and
fus3Δkss1Δ (cyan, Nc = 952)) bearing the Far1DS-NLS-RFP (left) and the Ste7DS-
NLS-YFP (right) stimulated with α-factor 1 μM. C. Histograms of the final response
of cells in the YFP and RFP channel. The asterisks designate distributions that
are significantly different (t-test, P <0.001) from the non-responding fus3Δkss1Δ
control.
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2.2.5. Cell wall integrity pathway
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Figure 2.21.: Engineering of a Mpk1-specific sensor. A Schematic of the Mpk1 sensor and align-
ment of the docking sites present in Mkk1 and Mkk2. A and B. Images of WT (A)
and (B) cells bearing the Mkk2DS1−33-NLS-RFP sensor. The cytoplasmic localiza-
tion of the sensor is signalling dependent.
Since the DS of the sensor dictates its specificity, we next tried to identify a DS for the MAPK
of the CWI pathway, Mpk1. Molina & al. [57] identified a sequence in the N-terminus of the
MAP2Ks Mkk1 and Mkk2 of S. cerevisiae that is conserved in other fungi and share some
homology with the consensus DS of MAPKs (figure 2.21.A). We therefore cloned the first 33
amino acids of Mkk2 in front of the NLS-RFP construct to generate an Mpk1-specific SKARS.
When integrated in cells, this sensor turned out to be mostly cytoplasmic, suggesting that a high
basal activity of the MAPK resulted in a constitutive phosphorylation of the sensor. Indeed,
this localization was Mpk1 activity-dependent, since deletion of the MAP3K Bck1 leads to an
enrichment of the sensor in the nucleus (figure 2.21.B).
To modulate the sensitivity of the sensor, we changed the distance separating the DS and the
NLS. Mkk2 N-terminal fragments of different lengths (from 1–27 to 1–150 amino acids) were
cloned in front of the NLS, hoping that the distance between the DS and the phosphorylation
sites would tune the ability of Mpk1 to phosphorylate the sensor. While we did not detect a
simple relationship between the length of the spacer and the basal level of nuclear localization of
the SKARS (figure 2.22), we could identify one construct, DS1-100, which displayed the highest
enrichment in nuclear fluorescence. Nonetheless, the nuclear enrichment of this SKARS was still
highly variable from cell to cell, suggesting that cells within a population can display a wide
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range of Mpk1 activities.
To test whether the Mkk2DS1−100 sensor could report on Mpk1 activation by acute cell wall
stress, cells were subjected to zymolyase treatment. It has been previously reported that in order
to activate Mpk1 upon zymolyase stress, activity of the HOG pathway via Ste11 and Pbs2 is
required (figure 2.23.A) [10]. Due to the very large difference in basal value between bck1Δ cells
on one side and WT and ste11Δ on the other, the latter strain offered a better comparison for
the response measured in WT cells (figure 2.23.B). When measured at the population level, the
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Figure 2.22.: Optimisation of the Cell Wall Integrity MAPK activity sensor. A and B. Images of
WT (A) and (B) cells bearing the Mkk2DS1−100-NLS-RFP sensor. The cells with
the Mkk2DS1−100-NLS-RFP sensor display a stronger basal nuclear enrichment
than cells with shorter versions of the sensor. B. Quantification of the basal level
of the sensor as function of the length of the Mkk2 fragment. C. Dynamics of
response of three versions of the sensors upon zymolyase stress (3U/ml).
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Figure 2.23.: Mpk1 activity dynamics upon zymolyase. A. Scheme of the activation of Mpk1 by
zymolyase or hypo-osmotic stress. B. Dynamic localization of the Mkk2DS1−100-
NLS-RFP sensor quantified by its change in nuclear-to-cytoplasmic ratio upon stim-
ulation by zymolyase 3 U/mL at time 0 in WT (red, Nc = 313), ste11Δ (blue, Nc
= 160), and bck1Δ (green, Nc = 80). C. Histograms of the final response after
zymolyase stress measured in the WT and two deletion strains. In panels C the
asterisks designate distributions that are significantly different (t-test, P <0.001)
from the bck1Δ control.
WT cells stressed with zymolyase displayed a slow gradual relocation of the sensor out of the
nucleus. As expected, this translocation was blocked in bck1Δ as well as in ste11Δ, implying that
Mpk1 was not activated in these mutants (figure 2.23.C). Note also that the basal Mpk1 activity
in a bck1Δ is higher than in a WT background. This would suggest that the CWI pathway is
strongly activated in growing condition. This could be explain by the fact that the cell-wall is
remodeled to form the bud during the polarized growth [137].
In order to verify that the response of the SKARS was specific to the Mpk1 pathway, we
also stressed cells with hypo-osmotic shock, where CWI activation is independent of the HOG
pathway (figure 2.23.A). To perform this experiment, cells were grown in medium complemented
with 1 M sorbitol. The cells were loaded in a microfluidic chip and the medium was exchanged
within seconds by medium containing 0.5 M sorbitol. The sensor transiently exited the nucleus
and returned to a stable value slightly lower than the original basal value. Ste11 was not required
for this response, as the ste11Δ cells displayed a response comparable to the WT cells. In bck1Δ
cells, only a small drop in the nuclear-to-cytoplasmic ratio was detected corresponding to the
expansion of the cell in the lower osmolarity medium (figure 2.24). Note also that the sensor
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Figure 2.24.: Mpk1 activity dynamics upon hypo-osmotic stress. A. Histograms of the final
response after zymolyase stress measured in the WT and two deletion strains. A.
Mpk1 sensor relocation upon hypo-osmotic shock performed in microfluidic devices
where the sorbitol concentration in the medium is lowered from 1 M to 0.5 M: WT
(red, Nc = 168), ste11Δ (blue, Nc = 180), and bck1Δ (green, Nc = 217). B.
Histograms of the final response after hypo-osmotic stress measured in the WT
and two deletion strains. In panels B the asterisks designate distributions that are
significantly different (t-test, P <0.001) from the bck1Δ control.
was more nuclear in cells grown in 1 M sorbitol, implying that the basal activity of the pathway
decreased under these conditions and that the deletion of Ste11 also influenced this basal activity
in hyper-osmotic medium.
2.2.6. Single cell response to cell wall damage
Because of the wide variety in basal activity of Mpk1 observed in the cell population, we wondered
how individual cells responded to zymolyase treatment. Figure 2.25.A represents a 2D-map of the
normalized response of more than 300 single cells sorted based on their final response. Using a
threshold of 0.2 for the final response, we can split the population in a group of responding (58%,
blue) and non-responding cells (green). Figure 2.25.B displays the average nuclear-to-cytoplasmic
ratio of the sensor as function of time for these two populations. The non-responding cells have
a strikingly lower level of sensor nuclear enrichment at the onset of the experiment denoting a
higher basal activity of the pathway in these cells (figure 2.25).
Since it has been reported that the activity of the Mpk1 pathway fluctuates during the cell cycle
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Figure 2.25.: Single cell responses upon zymolyase-induced cell wall damage. A. Heat map of
the response of individual cells bearing the SKARS Mkk2DS1−100-NLS-RFP to
zymolyase (3 U/mL). Each line represents the normalized response of one single
cell (Nc = 313). The cell traces were sorted based on the level of final response.
This measurement was used to classify the cells in a group of responding cells
(blue) and a group of non-responding cells (green). The basal level of each trace is
indicated in shades of red (from black to red, increasing basal level). These cells
also bear the cell cycle marker Whi5 and its level of nuclear enrichment is indicated
in shades of yellow (from black to yellow, increasing nuclear Whi5). B. Histogram
of the basal level in responding and non-responding cells. C. Histogram of the final
response measured in cells with or without nuclear enrichment of the cell cycle
marker Whi5 .
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and is higher in phases of polarized growth, we wondered whether the heterogeneity observed in
the response to zymolyase was dependent on cell cycle stage [137]. G1 cells in the population
were identified with a Whi5-mCitrine tag. The level of nuclear accumulation of Whi5 for each cell
is shown in figure 2.25.A; cells with nuclear Whi5 can be found in both the responding and non-
responding cells. Figure 2.25.C compares the final response of cells with nuclear and cytoplasmic
Whi5. A similar analysis was performed with Yox1-mCitrine cells, where the presence of the
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Figure 2.26.: Single cell responses upon zymolyase-induced cell wall damage: Yox1 marker.
The experiment from figure 2.25 is performed with a strain expressing the Yox1-
mCitrine marker. A. Histogram of the basal level in responding and non-responding
cells. B. Histogram of the final response measured in cells with or without nuclear
enrichment of the cell-cycle marker Yox1.
fluorescent protein in the nucleus identifies S-phase and early G2-phase cells (figure 2.26). There
was a tendency for G1 cells to respond stronger to the stimulus while dividing cells displayed a
decreased tendency to respond. However, there was no apparent inhibition of CWI signalling in
a cell cycle-dependent manner.
To modulate the basal activity of the pathway, we grew cells in low glucose (0.01 %, figure 2.27).
In this medium, the growth rate was slower, thus remodelling of the cell wall occurred on longer
time-scales, resulting in a lower constitutive basal activity of Mpk1. Indeed, we observed a global
increase in the basal nuclear enrichment of the sensor, resulting from the decreased activity of
Mpk1 (figure 2.27B). A larger fraction of the cells stressed with zymolyase under these conditions
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displayed an export of the sensor (figure 2.27C). Together, these results indicate that basal
activity of the CWI pathway is linked with cell growth rather than the cell cycle. Moreover, in
cells where Mpk1 is already activated by growth, we do not detect an additional effect due to
the cell wall stress induced by zymolyase within the time-frame of the experiment.
2.3. Discussion
In this chapter, we demonstrate the use of a new set of biosensors to measure the fast dynamics
of signal transduction in living single cells. The functional part of the sensor is a double NLS
sequence bearing four phosphorylation sites, which results in a three-fold enrichment of the
reporter in the nucleus of the cells under basal conditions. This is, however, not a static situation
and the sensor constantly shuttles back and forth between the cytoplasm and the nucleus. The
import into the nucleus is actively driven by the NLSs while the exit out of the nucleus is a
passive mechanism relying on diffusion due to the small molecular weight of the sensor [59].
Upon phosphorylation of the NLS, the import rate into the nucleus will be decreased due to
a lower affinity for importin, while the diffusion rate remains the same, resulting in a lower
concentration of the nuclear sensor. Note that phosphorylation can occur in both compartments
due to the constant exchange between both sensor pools. Therefore, measurement of kinase
activity is not restricted to one of these compartments, and the sensor measures the global
activity of the enzyme in the cell. Moreover, using a simple mathematical model, it is possible
to infer the amount of MAPK activity from the SKARS measurements.
The action of the kinase on the sensor is antagonized by phosphatases. These dephosphory-
lation events occur on the minute time-scale, as attested by our inhibition of Fus3 experiment
(figure 2.6). Since the signal transduction event in the MAPK cascade occurs on a similar
timescale, the SKARS are perfectly suitable to record these fast signalling events. Our sensor
ultimately measures the balance between kinase and phosphatase activities on the phosphory-
latable residues on the NLS. In MAPK pathways, signalling results in a change in the activation
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Figure 2.27.: Single cell analysis of Mpk1 activation by zymolyase in low glucose concentration.
A. Heat map of the response of individual cells bearing the SKARS Mkk2DS1−100-
NLS-RFP to zymolyase (3U/ml). Each line represents the normalized response of
one single cell (NC= 163). The cell traces were sorted based on the level of Final
Response. This measurement was used to classify the cells in a group of responding
cells (blue) and a group of non-responding cells (green). The Basal Level of each
trace is indicated in shades of red (from black to red, increasing basal level). B.
Histogram of the Basal Level of nuclear enrichement in 0.01% and 2% glucose. C.
Fraction of responding cells in 2% and 0.01% glucose. Mean and standard deviation
of four experiments are shown. D. Time-course of the Nuclear to cytoplasmic ratio
for responding and non-responding cells at 0.01% and 2% glucose. E. Histogram
of the Basal Level for responding and non-responding cells grown in 0.01% and 2%
glucose.
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of the MAPKs while the phosphatases possess a relatively stable and constitutive activity. Part
of the variability observed with our sensor could possibly arise from differences in phosphatase
activity between individual cells.
Förster Resonance Energy Transfer (FRET) probes have been generated to monitor the activity
of kinases in cells [124, 38, 79]. In comparison, the SKARS possesses two main advantages. First,
the requirement of the FRET probe to use two fluorophores together with the limited number of
available FRET pairs makes it difficult to combine two different FRET sensors in the same cell.
In comparison, our system uses a single fluorescent protein and we have showed the correlated
measurements of two reporters in the same cell. This number could be increased to three or four
by combining different fluorescent protein spectral variants [110].
The second advantage of our system lies in it is modularity. The optimization of the FRET
sensor is a difficult task because the orientation of the two fluorophores has to be adjusted and
depends directly on the structure of the sensor’s active site [39, 62]. In the SKARS, the substrate
site and the fluorescent protein are independent of each other, and can therefore be interchanged
without affecting each other. Indeed, the fluorescent moiety was exchanged between mCherry
and mCitrine without affecting the dynamics of the response. Similarly, we could exchange the
Ste7DS with a Far1DS or Mkk2DS to confer specificity of the sensor towards Fus3 or Mpk1,
respectively. We also demonstrated that the sensitivity of the sensor can be tuned by changing
the distance between the DS and the phosphorylatable residues in the NLS.
Interestingly, NLSs as well as MAPK DSs are conserved domains throughout all eukaryotes.
This implies that a similar strategy can be adopted to develop sensors for higher eukaryotes. In
fact, other kinase sensors based on phosphorylatable NLS or nuclear exclusion sequences have
been described in the literature both in yeast and in higher eukaryotes by using small domains
of proteins known to relocalize [115, 31]. In parallel to the development of our biosensor, Regot
& al. [99] have used a similar strategy to quantify MAPK activity in mammalian cells. This
underscores the wide applicability of the approach presented here. In this work, we used a
synthetic biology approach to design de novo a MAPK substrate that can undergo relocation.
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Using a similar strategy, we can also envision measuring other enzymatic activities in living cells.
Extending the range of available SKARS for other kinases should be relatively straightforward
if they require a DS and possess a short consensus motif. Other kinases with longer consensus
phosphorylation sites could also be monitored provided that phosphorylatable residues can be
placed close enough to the NLS to influence its association with the importin.
2.4. Conclusion
Using these biosensors to probe MAPK activity in the mating and cell wall integrity pathways,
we could reveal a large heterogeneity in the response between cells within an isogenic population.
For the mating pathway, this variability can be explained by extrinsic differences between cells.
While it has been known that the response to mating pheromone was cell cycle-dependent with an
inhibition of the pathway during the S phase, we could demonstrate with these sensors that there
is also a different kinetic activation of the pathway between a fraction of G2/M cells and cells
in the G1 phase. In the S phase, the scaffold protein Ste5 is phosphorylated by the Cln2/Cdc28
complex to prevent its recruitment at the plasma membrane via the PM domain [116]. It remains
to be seen whether the same mechanism is involved in the observed difference in the kinetics
between G1 and G2/M cells. In the CWI pathway, a heterogeneity in the response can also be
observed between individual cells. It cannot be attributed to cell cycle-specific cues, but rather
to the general growth of cells that induce more or less basal activity of the Mpk1 MAPK.
These two examples confirm the notion that MAPK pathways are not isolated signal transduc-
tion cascades, but are embedded in the global signalling network of the cell. MAPK pathways
can integrate these intra-cellular signals to modulate their output, and in turn the MAPK activ-
ity can impact on cellular processes such as the cell cycle, metabolism, or growth. The ability
to measure MAPK activity in single cells provided by the SKARS enables us to uncover these
regulations and provides the opportunity to identify the mechanistic links that connect MAPK
pathways to other cellular processes. In general, the SKARS technology enables the direct mea-
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surements of enzymatic activity in living cells and as such can become an important tool for
system biology. Its use will allow the identification of new regulatory mechanisms present in
these signalling cascades and, in turn, will enable to build more accurate mathematical models
of the dynamic events taking place in these pathways.
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3. Dynamic single cell study of the mating
and cell-cycle cross-inhibition mechanism.
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3. Mating and cell-cycle cross-inhibition mechanism.
3.1. Background
Mating process. Unicellular yeasts are powerful model systems to understand the cell-fate
decision making. In Saccharomyces cerevisiae, when two haploid cells of opposite mating type
(MAT-a and MAT-α) are in close proximity, two paths can be taken: divide or mate. All cells
in a mating mixture secrete pheromones to indicate their relative position to the surrounding
potential partners. Once the pheromone is sensed, the future partners arrests their cell cycle
progression in G1 and start a chemotropic polarisation leading to the formation of a bulge
(shmoo) oriented toward each other [128, 7, 107, 27]. The shmoos grow until cells touch each
other. Following this, both fuse and mix their DNA content to form a diploid cell. The resulting
diploid faces a new choice influenced by the environmental conditions. If the environment is
suitable for growth, the cell divides. However, under nitrogen deprived conditions, the diploid
cell starts the meiosis and forms haploid spores that will wait for better conditions to germinate
[73].
As we can see, the budding yeast life cycle contains various steps in which cells have to choose
between multiple fates. This cell-fate decision is mostly controlled through signalling cascades,
such as MAPK pathways, that are well conserved among eukaryotes [96, 107, 89, 44]. To sum up,
the mating is a prototypical process extensively studied as it requires the regulation of conserved
signalling cascades.
The mating MAPK pathway. The signalling cascade activated during the mating is very well
characterised 3.1. The pheromone binds a receptor (Ste2) that promotes the conversion of GDP
into GTP on the α subunit (Gpa1) of an heterotrimeric G protein. The nucleotide exchange
leads to the dissociation of Gpa1 from the β-γ subunit (Ste4-Ste18)[128]. The free Ste4-Ste18
complex promotes signal transduction by activating the PAK-like kinase Ste20 [67] and the
scaffold protein Ste5 [55]. The Ste5 forms a complex with a conserved MAPK pathway module
composed of Ste11, Ste7 and Fus3 [128, 7, 107]. The localisation of Ste5 at the membrane
brings the MAPK module close to the MAP4K Ste20 that triggers a phosphorylation cascade.
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Ste20 activates the MAP3K Ste11, which activates the MAP2K Ste7 that then activates the two
MAPK Fus3 and Kss1. Active MAPKs spread the signal to various substrates. Among them
we find transcription factors such as Dig1, Dig2 and Ste12, which regulates the transcription of
approximately 200 genes [103, 7, 107]. Some of these genes encode for signalling components but
also for proteins involved in cell polarity and fusion [103].
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Figure 3.1.: Schematic representation of the
Saccharomyces cerevisiae mating
pathway.
Mating and cell cycle cross-inhibition. Al-
though Fus3 is thought to be the most im-
portant MAPK, the mating can still occur if
Kss1 is expressed alone [106]. This suggests
that both MAPKs have some redundant func-
tions. However, only Fus3 activates the Cyc-
lin Kinase Inhibitor (CKI) Far1. Far1 is one
of the most important targets of the mating
pathway. Once activated by Fus3, this protein
regulates the Cyclin Dependent Kinase (CDK)
Cdc28 in G1 by outcompeting with the cyclins
Cln1/2. The Far1 CKI prevents a proper bind-
ing of the CLN to their substrates. Moreover,
Far1 is thought to directly inhibit the activity
of Cdc28. This results in the inhibition of the
CDK and therefore the arrest of the cell cycle
progression in G1 [91, 87]. In parallel, the cell cycle was reported to inhibit the mating through
two major mechanisms. The first one consists in the degradation of Far1 at the transition from
G1 to S-phase (also named as the START checkpoint) and requires a complex formed by the
CDK and the first expressed late-G1/early-S Cyclin Cln3 [72, 53]. The second mechanism was
discovered by the group of Peter Pryciak in 2007 and consists in the direct inhibition of the
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MAPK pathway through the scaffold protein Ste5. First of all, they identified a plasma mem-
brane interaction domain (PM) at the N-terminus end of Ste5 that is required to enhance the
signal transduction through the MAPK pathway [93]. Interaction of this domain with the mem-
brane acts in synergy with the interaction with the Gβ subunit and stabilises the scaffold at
the membrane [131]. In addition, they found that this PM is phosphorylated in S-phase by the
complex CDK-CLN Cdc28-Cln1/2. This leads to the detachment of the MAPK module from
the Gβ and thus to a lower signal transduction efficiency [116]. To conclude, the mating and the
cell cycle are tightly linked by a cross-inhibition mechanism.
Current assay limitations. Although the current model of cross-inhibition mechanism is well
established, the available tools are limited in term of qualitative and quantitative data acquisi-
tion. Far1 dependent arrest of the cell cycle was observed using halo assay or through inhibition
of the Cdc28-Cln1/2 activity [88, 87]. In these conditions, the arrest was studyied at the whole
population level. On the other hand, cells in culture do not progress synchronously in their
cell cycle. This can be a problem, as the dynamic MAPK activity might be different in each
cell cycle phase [26, 25]. Thus, synchronisation strategies, using either Cdc28/Cdc15 thermo-
sensitive mutant strains or chemicals such as hydroxyurea, are commonly used to study the
mechanism of inhibition of the mating pathway driven by the cell cycle[116, 11, 72]. In addi-
tion, phosphorylation of the Ste5 scaffold protein by Cdc28-Cln2, and the downstream effect on
the signalling cascade activity, were described using Western Blot or gene expression reporter
methods in strains overexpressing cyclins [129, 116]. Consequently, all these methods either use
very artificial conditions and report the behaviour of the whole population, or do not specifically
measure the activity state of signalling cascades. These are major limitations, since the cell cycle
and mating cross-inhibition mechanism induce an heterogeneous pheromone response. A proper
study of this mechanism requires single cell level measurement.
Recently, some groups attempt to clarify the MAPK activity pattern in all phases of the cell
cycle. The group of Andre Levchenko measured the mating MAPK activity at the single cell level
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using a FRET sensor. The group of Jan Skotheim, tracked the cell cycle progression of single
cells based on the Whi5 sub-cellular localisation. Although these two groups acutely measured
either the mating pathway or the cell cycle progression, they quantified less efficiently the second
(cell shape observation to identify the cell cycle stage, and transcriptional reporters or protein
accumulation at the shmoo tip to measure mating pathway activation. [19, 29, 28].
By combining synthetic biology, live cell imaging and computational data analysis, we propose
to revisit the model describing the relationship between mating and cell cycle through dynamic
measurements of the MAPK and the CDK activities, both simultaneously, and in live single cells.
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3.2. Result
3.2.1. SKARS and Whi5: MAPK and CDK activity sensors.
Whi5 and SKARS: Structure and behaviour. In order to study how mating and cell cycle
interact with each other, we choose to quantify the activity state of the signalling cascades that
regulate these two processes. Moreover, as the cell cycle progression is different from cell to cell,
we performed this analysis at the single cell level. Cell shape observation and fluorescent gene
expression reporters are the most common strategies used to monitor cell cycle progression and
mating activation. However, these strategies have several weaknesses that limit their reliability
to report the dynamic activity state of a given signalling cascade [72, 80, 3, 86]. To counteract
this problem, we imagined a system in which the difference of fluorescent protein in and out
of the nucleus is translated in kinase activity. Such approach has the advantage to directly
probe one particular node of a signalling cascade using a process that is dynamically closer to
phosphorylation kinetic than to transcription. In the context of our study, two independent
sensors will be used to simultaneously measure the activation states of the mating MAPK and
the cell cycle master regulator Cdc28 activity in each individual cell.
MAPKs DS NLSmCherry MAPKs
DS NLSmCherry
P
- Pheromone + Pheromone
CdkCdk CitrineWhi5
P
CitrineWhi5
G1-Phase S-G2-M-PhasesA B
Figure 3.2.: Schematic representation of the cell cycle CDK activity sensor (Whi5) and the
synthetic mating MAPK activity sensor (SKARS).
As explained in the chapter Introduction, Whi5 is a repressor of G1 genes transcription [23, 21]
and has been previously used as a marker for G1 entry and exit [9, 25]. The nuclear shuttling
of the protein is controlled by the Cyclin Dependent Kinase (CDK) called Cdc28, that phos-
phorylates the transcription factor (TF). In G1, Whi5 is in its non-phosphorylated nuclear form,
as the CDK is not active (figure 3.2.A). Once the cell transits from the G1 phase to the S-phase
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(START chaeckpoint), the CDK phosphorylates Whi5 and triggers its cytoplasmic accumulation.
In order to visualise this dynamic sub-cellular change, the endogenous Whi5 protein was tagged
on its C-terminus with the mCitrine fluorescent protein.
To measure the dynamic activity of the mating signalling cascade we use the SKARS tech-
nology described in the chapter 2 [30]. We use the Ste7DS-SKARS configuration to report the
kinase activity of the two MAPKs Fus3 and Kss1 (figure 3.2.B).
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Figure 3.3.: A. Fluorescent microscopy images of cells observed during time lapses experi-
ment. Pictures show WT cells expressing a Hta2-tdiRFP (nucleus), a Ste7ND-
SKARS-mCFP (Corrector), a Ste7DS-SKARS-mCherry (MAPK sensor) and a
Whi5-mCitrine. Each fluorescent channel was acquired every five minutes for two
hours. B. CDK activity reported as function of the time relative to G1-entry. Time
lapse movie from A. was analysed using the YeastQuant platform (See appendix Ma-
terial and methods 55 and [85]). The CDK activity corresponds to the fluorescent
intensity ratio between the cytoplasm and the nucleus of Whi5. 70 cells that exhibit
at least one impulse of CDK activity were selected. The time of impulse appearance
is considered as the time point 0 minutesand serve as a temporal reference (see exp
procedure and FigSup1).
Whi5 sub-cellular localisation reports on the dynamic of CDK activity. To confirm that
both sensors exhibit the expected sub-cellular localisation at the single cell level, we express the
two systems into the yeast strain W303 and ran two hours time lapse (TL) experiments using
an epi-fluorescence microscope. Figure 3.3.B shows one representative cell that expresses the
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Whi5-mCitrine (Yellow) and Ste7DS-SKARS (Red). In order to identify the nucleus area, we
also tagged the Hta2 histone with a tandem dimer infra-red fluorescent protein (tdiRFP, purple).
In the first frame, the cell shows a strong yellow nuclear staining. This signal disappears after
30 minutes but reappears at 90 minutes. The loss of nuclear fluorescence correlates with the
bud appearance at 30 minutes (S-G2-phases) and ends once the cell completes the cytokinesis
(compare Whi5-mCitrine channel with BF0 Hta2-tdiRFP). This demonstrates that Whi5 trans-
locates from the nucleus to the cytoplasm after S-phase entry and re-enters into the nucleus after
G1-entry as expected.
The Whi5 nuclear translocation depends on the phosphorylation driven by the CDK [9, 25].
To quantitatively report on the activity level of the CDK we used the YeastQuant platform to
segment and track the nucleus and the cytoplasm of hundreds of cells along the time lapse movies
[85] (figure 2.4). The CDK activity was defined as the ratio of fluorescence intensity between the
cytoplasm and the nucleus in the yellow channel. This calculation was performed at each time
point and for all the cells tracked from the beginning to the end of the experiment. The dynamic
of CDK activity appears to be extremely heterogeneous between cells. Each single cell shows
shifted negative pulses of CDK activity consistent with the fact that the cell cycle progresses
independently from cell to cell (figure 3.4A). These delayed signals are problematic to observe a
similar general trend of CDK activity. To overcome this problem, cell traces were aligned based
on the time at which the CDK activity reaches its minimal value (G1 phase). This procedure
will be further referred as “synchronisation”. This synchronisation strategy is very efficient also
for cells that transit through G1 (figure 3.4.A, B).
We applied this method to confirm that the Whi5 oscillation period correlates with the reported
growth speed of budding yeast. As shown in figure 3.3.B, the average synchronised CDK activity
oscillates periodically (filled line). This is confirmed at the single cell level, as individual traces
exhibit a similar trend (dotted lines). The period separating two negative pulses agrees with
the reported time required for a cell to start and complete one cell cycle (i.e. 90 minutes).
Consequently, the dynamic of CDK activity deduced from the Whi5 sub-cellular localisation,
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Figure 3.4.: Synchronisation of CDK activity based on the time cells enter G1. WT cells ex-
pressing SKARS and Whi5 sensor were imaged for 2 h with 5 minutes intervals.
Images were analysed using the YeastQuant platform and the CDK activity was
calculated as the yellow fluorescent intensity ratio between the cytoplasm and the
nucleus for each individual cell and at each time point(A, B). A. Cells were selected
since their CDK signal shows at least one impulse event. The CDK activity of the
selected cells was reported as function of time. B. The time at which the CDK
activity traces reaches its minimum value was taken as a temporal reference (t=0).
The CDK activity traces from B were plotted related to these values.
acutely reports on the cell cycle progression of each individual cell. Moreover, the in silico cell
synchronisation based on the G1 entry is an extremely powerful method to get a representative
picture of cell behaviour at a given cell cycle stage.
Correction of the SKARS signal. The Ste7DS-SKARS presented in the previous chapter is
used to measure the MAPK activity of Fus3 and Kss1. For simplification, this construct will be
further referred as "SKARS" chapter 2. A red nuclear staining is observed at all frames of the
time lapse experiment performed in figure 3.3.A. This confirms that in basal conditions the sensor
is actively imported into the nucleus at all cell cycle phases. However, a small decrease in nuclear
intensity can be observed at 60 minutes. To find out whether this is due to cell cycle dependent
regulation of the MAPK basal activity, a non-functional SKARS containing point mutations in
its interaction domain was used as an internal control (CFP channel,figure 2.5, figure 3.3.A).
For simplification, this construct will be further referred as "Corrector". Figure 3.3.A shows a
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nuclear staining reduction at 60 minutes in the Corrector channel. Thus, the Corrector is not
imported into the nucleus with the same efficiency throughout the cell cycle.
To completely reject the involvement of the mating pathway in the reduced nuclear importation
of the SKARS and the corrector, we performed the same experiment in a ste5Δ strain, a mating
signalling dead mutant. We then decided to focus on the sub-population of cells that enters in G1,
since the largest nuclear signal change seems to happen in this cell cycle phase transition. After
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Figure 3.5.: Optimization of the MAPK activity quantification. Time lapse experiments and
image analysis was performed as previously described (45 minutes long, 3 minutes
interval). A. Synchronised CDK activity signals. CDK activity of cells entering in
G1 plotted relative to the start of the CDK signal degradation. B. Dynamic sub-
cellular localisation of SKARS and Corrector at S-G2-M to G1 phases transition.
SKARS and Corrector values from A were extracted and N/C ratio of both sensors
were calculated. Noise attenuation was obtained by calculating the ratio between
the N/C ratio of corrector divided the N/C ratio of SKARS (Corr. Ratio). For
comparison, N/C ratios and Corr. ratio were normalised relative to their respective
mean and then plotted relative to the time cells enter in G1 as in A. C. N/C ratio
noise reduction. Standard errors of normalised N/C ratio and corrected ratio along
the time axis calculated for all tracked cells and plotted as boxplot.
CDK activity based synchronisation (figure 3.5.A), the corresponding normalised SKARS and
Corrector N/C ratio are plotted relative to the time of G1 entry (figure 3.5.B). The ste5Δ mutant
exhibits a 40% increase of the N/C ratio of both SKARS and Corrector during the entry into G1
(figure 3.5.B). This goes in the direction of the qualitative observations done in figure 3.3.B and
confirms that the sensor’s nuclear import efficiency changes from S- to G1-phase. However, no
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differences between SKARS and Corrector N/C ratio is observed. The corrected ratio median
(CorrectorN/CSKARSN/C ) remains flat with a reduced 25-75 percentile shaded area. This confirms that the
SKARS and Corrector ratios show the same dynamic and that both signals can suppress each
other (figure 3.5.C). Consequently, SKARS signal is subjected to small fluctuations independently
on Fus3 and Kss1 activity. This noise is reduced by two folds when SKARS and Corrector signals
are combined. Based on this analysis, we will now on consider the corrected ratio as the MAPK
activity.
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Figure 3.6.: Dynamic MAPK activity in unstimulated conditions. Time-lapse and analysis were
performed as in figure 3.5 but in a WT background.
Same analysis as performed in figure 3.5 was reproduced in a WT background. Interestingly,
the SKARS and the Corrector signals do not overlap when cells finish to enter in G1 (10-30
min, figure 3.6.A and B). As a consequence, the corrected ratio shows an oscillation pattern.
The 25-75 percentile area surrounding the Corrected ratio median remains constant along the
time. This suggests that the we removed artifactual noise from the the SKARS signal using the
Corrector internal control. . The oscillation pattern observed from the corrected ratio suggests
that in absence of pheromone, the MAPK activity is regulated in a cell cycle-dependent manner.
In growing conditions, kinases are down regulated at the interplay between S-G2-M and G1.
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Figure 3.7.: A. SKARS sub-cellular localisation prior and after pheromone treatment. The strain
from figure 3.3 is imaged every three minutes for 45 minutes. α-factor is added nine
minutes after time-lapses start. This is referred as the time point 0. Pictures show
two representative cells. B. MAPK activity reported as function of time. Time-
lapse movies from A. and from a mating signalling dead mutant strain (ste5Δ) are
analysed as previously. The MAPK activity corresponds to the Corrected Ratio
described in figure 3.5 and 3.6.
The corrected SKARS signal reports on the activity of the mating MAPK. We have pre-
viously shown that the SKARS sensor accumulates into the cytoplasm of cells stimulated with
exogenous pheromone (2.2.1, figure 2.3, [30]). To confirm this, we performed time lapse experi-
ments in which cells were stimulated with 1μM of α-factor 6 minutes after the beginning of the
imaging (figure 3.7.A). Cells show a strong nuclear red signal. Immediately after pheromone ad-
dition (time point 0), the nuclear red signal decreases. The corrector, however, remains nuclear
during the time-lapse, as well as the Hta2-tag. Consequently, stimulation of cells with pheromone
induces a cytoplasmic accumulation of the SKARS.
The loss of nuclear signal is stronger in the upper cell which imply that both cells exhibit
different MAPK activation after stimulation. In order to confirm this heterogeneous MAPK
activation, we performed time lapse movies with the WT or with a mating signalling dead
mutant (ste5Δ). In ste5Δ background, the median and random chosen single cell traces show
the same constant low MAPK activity before and after pheromone treatment. This is consistent
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with the fact that, in this mutant, the mating pathway is broken (figure 3.7.B). On average,
the MAPK activity in WT background increases and reaches a plateau in less than five minutes
following stimulation. At the single cell level, we can see that the MAPK activity increases to
an intermediate value (25% increase of the signal right after stimulation) followed by a delayed
two-fold increase (figure 3.7.B, WT cells). These results show that even though cells are exposed
to the same pheromone concentration, they do not activate the mating pathway with the same
dynamic, suggesting that the environmental change is not perceived in the same way.
To sum up, SKARS and Whi5 report on the dynamic activity of the mating MAPKs Fus3 and
Kss1 and the CDK Cdc28 respectively. The measurement of both pathways is obtained for hun-
dreds of individual living cells and with a temporal resolution of two minutes. This high temporal
resolution enables to track rapid signal dynamic changes, often missed with classical protein ex-
pression reporters’ strategies. The use of the Whi5 TF as a sensor enables to track the cell cycle
progression without synchronizing cells with chemicals or genetically engineered mutants. On
the MAPK side, we improved the SKARS technology using a Corrector as a permanent internal
control and reduced the single cell trace noise by two-folds. This SKARS optimisation leads
to the observation that the cell cycle regulates the mating not only in pheromone stimulated
conditions but also in normal growing conditions. Overall, these results show that SKARS and
Whi5 can be used to measure mating and cell cycle signalling cascade activity simultaneously
and in the same cell.
3.2.2. Single cell analysis of the MAPK activity signal.
Dynamic activity of the mating MAPKs in G1- and in S-phase. It was reported that the
mating pathway cannot be activated in all the cell cycle phases [81, 53, 50, 72, 129]. To confirm
that the MAPK pathway is targeted by this cell cycle-dependent regulation, we performed time
lapse experiments with pheromone stimulation as in figure 3.7 and extracted the MAPK activity
during the cell cycle progression. The imaged strain expressed the same fluorescent markers as
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in figure 3.7 and did not express the pheromone protease Bar1, so that cells were continuously
stimulated with the same concentration of pheromone [8, 27]. After image quantification, MAPK
and CDK activities were calculated. We then performed a cell clustering based on the dynamic
CDK activity of each individual cell and reported the average MAPK activity corresponding to
each group.
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Figure 3.8.: Pheromone induced MAPK activation of cells in G1 or S-G2-M phases. Time-lapse
experiment of 45 minutes with 3 minutes intervals were performed as in figure 3.7 on
a strain deleted for the gene encoding the Bar1 protease. MAPK and CDK activities
were calculated for 738 cells tracked from the beginning to the end of the time lapse.
Single cells were sorted in different clusters by comparing their CDK activity pre-
/post-stimulation: (i) low/low : G1-locked. (ii) high/high : S-G2-M. (iii) low/high is
S-entry. (iiii) high/low : G1-entry. Both CDK and corresponding MAPK activities
were averaged and are plotted on two independent axis in relation to the time of
pheromone addition (filled line: median, shaded area: 25-75 percentile). The figure
shows CDK and MAPK activity of G1-locked (A, cell fraction: 20%) and S-G2-M
(B, cell fraction: 35%) cells. Both CDK and corresponding MAPK activities are
averaged and plotted on two independent axis relatives to the time of pheromone
addition (filled line: median, shaded area: 25-75 percentile).
The first two clusters contain cells with a sustained low or high level of CDK activity and
correspond to cells that remain either in G1 (G1-locked, figure 3.8.A) or in S-G2-M (S-G2-M-
locked, figure 3.8.B) respectively. G1-locked cells exhibit a sustained low CDK activity. The
corresponding MAPK activity shows a two folds increase in less than five minutes post stimu-
lation, followed by a stabilisation of the signal until the end of the experiment (figure 3.8.A).
Unlike for the G1-locked cells, we observe only a minor MAPK response of the S-G2-M-locked
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cluster (1.25 fold increase). Consequently, the mating pathway is strongly activated in G1 and
much less in S-G2-M. These results support the reported observations showing that the mating
is not induced during the S-phase. Moreover, we are able to show that the inhibition mechan-
ism consists in the reduction of the MAPK activation after pheromone stimulation without its
complete abrogation.
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Figure 3.9.: CDK and MAPK activities relative to G1-entry. WT cells expressing SKARS and
Whi5 sensors were imaged for 45 minutes with three minutes intervals. 1μM α-factor
was added to the well nine minutes after the acquisition start. Cells entering in G1
were selected as the CDK signal start above 0.55 and end below this threshold. A.
The dynamic of CDK and MAPK activities of randomly selected cells from the G1-
entry cluster are plotted relative to the time of induction. E. The last time point at
which the CDK activity remains below 0.55 is taken as a temporal reference. CDK
and MAPK activities from A are plotted relative to this reference time.
Cells entering G1 exhibit heterogeneous MAPK signal patterns. As discussed in the previous
paragraph, the Whi5 sensor allows cell cycle progression tracking of individual cells. While
previous studies relied on chemical synchronisation to study signalling in various cell cycle phases,
our strategy enables us to use the natural variability of the sample. This is an interesting feature
that provides information about cells during their transition between cell cycle stages.
Cells exposed to pheromone while they are in S-phase, do not stop their progression, but were
reported to complete their cell cycle to G1 [81]. We found indeed that 30% of the population of
cells tracked from begining to the end of the time lapse experiment enters in G1 after α-factor
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addition. This entry happens in a delayed manner, as cells are not synchronised in their cell cycle
progression. The corresponding dynamic of MAPK activity seems to follow the same trend, as
single cell red curves are shifted from each other (figure 3.9.A). These results suggest that in this
cluster, the average MAPK activity relative to the time of induction does not illustrate well how
the pathway is dynamically activated at the single cell level (figure 3.9.A, compare red median
and red single traces).
As the difference of MAPK activity between S-G2-M-locked cells and G1-locked cells, we
thought that plotting MAPK activity relative to the time at which cells enter in G1 would
enable to observe a more representative pattern than the signal of each single cell. To do this, we
performed cell synchronisation based on the CDK activity as previously described (figure 3.9.B).
After synchronisation, the CDK activity traces are well aligned. The corresponding MAPK
channel also shows a good overlap of single traces, suggesting that the major change of MAPK
activity occurs at the transition between S-G2-M and G1 and not after pheromone treatment.
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Figure 3.10.: MAPK activity of cells in transition between cell-cycle phases. The figure presents
the MAPK activity of two clusters obtained from the experiment described in fig-
ure 3.8. CDK activity of G1-entry cells drops post-stimulation (A, G1-entry, 33%).
S-entry cells show the opposite signal pattern (B, S-entry, 10%). Both CDK and
corresponding MAPK activities are averaged and plotted on two independent axes
relative to the G1-entry time (G1-entry) or relative to the pheromone addition
(S-entry). Time points prior stimulation are removed from the analysis after syn-
chronisation of the G1-entry cells traces.
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MAPK is activated only in G1 We observed that S-G2-M-locked cells slightly activate the
mating pathway (figure 3.8.B). One question that can be addresses is how the dynamic activity
of the MAPK evolves when cells enter in G1 after stimulation. To obtain this information, we
first identified cells that enter in G1 and then synchronised their MAPK and CDK traces in
relation to the G1-entry time point. Note also that the time points preceding the stimulation
were rejected from the analysis in order to focus only on the period in which cells were exposed
to pheromone. The CDK and MAPK activities are then plotted as in figure 3.8. Prior the
CDK activity drop, the MAPK activity is at the level of the S-G2-M phase cells. Then, activity
increases to the level of the G1-locked during the CDK signal degradation. Interestingly, MAPK
activity starts to increase only when the CDK activity reaches its minimum level. This indicates
that the mating signalling cascade recovers its full activation capacity after cells have completed
their cell cycle. These last results dissent from previous studies which instead reported that
during G2 the mating pathway activity increases gradually [19, 129, 81].
In addition to start a new transcriptional program and recruiting the polarisation machinery to
form the shmoo, MAPK activation also induces to cell cycle arrest in G1 [91, 87]. Consequently,
we do not expect to find cells that enter in S-phase after being stimulated with pheromone.
Surprisingly, about 10% of the population exhibits a low CDK activity before stimulation and
high CDK activity after stimulation. Even more surprisingly, although the CDK activity is
almost at its maximum value during stimulation, the corresponding MAPK signal shows a pulse
pattern with a peak at 75% of the G1-locked maximum value and a recovery that stabilises at
the level recorded for S-G2-M cells (figure 3.10.B). Consequently, we see that a significant part
of the population is committing to S-entry but remains still transiently sensitive to exogenous
pheromone addition. Thus, small temporal windows separate the phase of choice between G1-
arrest and cell-cycle commitment and the phase during which the MAPK is inhibited by the cell
cycle.
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Figure 3.11.: Contribution of cluster signals to the average MAPK activity. A. Dynamic MAPK
activity of the four main cell-cycle clusters. The blue curve represent the MAPK
activity recorded for the whole population. Line correspond to means of medians
from at least three replicates. Error bars are standard deviations. B. MAPK
activity from A. are plotted relative to the fraction of cells in each sub-population.
Each coloured area represent the cumulative effect of the signal of the given cluster
plus the signal of the cluster located below it.
Cell-to-cell variability of the MAPK signal is a downstream effect of delayed cell cycle
progression. A clustering based on the CDK activity enables us to identify four cell populations
exhibiting different MAPK dynamic patterns. To confirm the relevancy of these clusters and
compare their mating pathway dynamic activation with the one of the whole population, we
perform the clustering on four independent replicates and calculate the mean of the replicates
median MAPK activity for each cluster (figure 3.11.A). Dynamic MAPK activities is very similar
from replicate to replicate, independently on the cluster. In addition, 95% of the cell population
is well sorted in the four clusters. The last 5% is a group of cells defined as transiting “through
G1” as they transiently activate the CDK. For the time being, this cluster is ignored because
most of the cells show noisy CDK activity. Altogether, the various MAPK activity patterns
observed result from cell cycle regulatory mechanisms only.
The average dynamic MAPK activity shows a similar trend to the one previously observed
using western blot assay [54, 43, 77, 136]. The average signal first shows a five minute-long sharp
increase, followed by a small overshoot ending at 10 minutes and a sustained slower increase
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(figure 3.11.B, ). To investigate the contribution of all clusters to the average MAPK activity, we
plotted the cumulative MAPK activity in relation to the fraction of cells in each sub-population.
The major sub-populations contributing to the first fast increase are the G1-locked and the
S-G2-M clusters. The sustained increase of the signal is generated by G1-entry cells which
progressively accumulate in G1. The small overshoot is due to the presence of the S-entry
population (figure 3.11.B). All of this shows that the average MAPK activity signal can be
divided in four main signals. Average population analysis allows to observe the response of a
whole population into a given condition. Single cell analysis, however, enables to observe the
variability of the response in this condition.
To sum up, our single cell analysis strategy enables to extract data from one time-lapse ex-
periment that summarise decades of observation on the mating and cell cycle cross-inhibition.
Although the mating pathway is heterogeneously activated from cell to cell, we succeed in sum-
marising this variability by sorting cells into five well-represented categories. The CDK activity
based clustering confirmed that cells in S-phase induce four times less the mating MAPK path-
way than those in G1. Moreover, we show that the full activation capacity is reached only during
G1 and that a small fraction of cells committed to S-phase transiently activates the signalling
cascade. All MAPK activity signals from these clusters show very different patterns. Thus,
considering the average MAPK activity is not enough to well determine the fate of each indi-
vidual cell in this experimental condition. Finally, the five clusters isolated from the CDK kinase
dynamic exhibit different dynamic MAPK activity signals that are representative of how the
mating pathway gets activated at the single cell level.
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3.2.3. The mating pathway regulates the cell cycle in a pheromone
dose-dependent manner.
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Figure 3.12.: MAPK signal degradation induced by the Bar1 protease. Time-lapse experiments
are performed as in figure 3.7 on WT and bar1Δ cells. Stimulation was applied
with various α-factor concentrations. MAPK activity is calculated, averaged and
plotted relative to the induction time for the whole population. Each curve is the
mean of at least three replicates. Error bars are standard deviations.
MAPK activation is pheromone dose-dependent. Individual cells secrete pheromone to in-
dicate their relative position in a mating mixture [8, 27, 58]. The pheromone can freely diffuse
into the environment, leading to the formation of a concentration gradient around the cell. The
cells respond to this gradient by forming a shmoo. The mating pathway activity was reported
to gradually change depending on the pheromone amount [46, 77]. In order to confirm this,
we performed the same experiment as in 3.2.2 with increasing concentrations of α-factor and
quantified the corresponding MAPK activity.
At the whole population level, WT cells stimulated with 1μΜ of pheromone exhibit an average
kinase activity signal similar to what we already observed in figure 3.11. The MAPK signal first
reaches a peak in less than three minutes, then slightly drops to slowly increase again in the end
(figure 3.12.A). Stimulation with media without α-factor leads to a flat curve as expected. At
intermediate pheromone concentrations, we observe a reduction of the signal peak as the α-factor
concentration drops. This suggests that the MAPK pathway is activated in a dose dependent
manner as reported [46, 136]. At these intermediate concentrations, we observe a slow signal
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degradation until reaching the pre-stimulation value. This slow and constant loss of MAPK
activity might be induced by pheromone degradation driven by the protease Bar1 (see 3.2.2). To
confirm this, we performed the same set of experiments in a strain deleted for the gene encoding
this protease. As expected, the signal drop disappears at all intermediate concentrations in this
background (figure 3.12.B).
To summarise, the MAPK is activated in a pheromone dose-dependent manner. Thus, we can
artificially tune the level of MAPK activity. Although the Bar1 protease induces a MAPK signal
degradation, this loss of signal can be circumvented using a strain deleted for the gene encoding
this protein. Thus, in the following experiments, the bar1Δ background will be our reference
strain and will be referred as WT.
The mating dependent cell cycle arrest in G1 is MAPK activation dose-dependent The
MAPK activity of cells stimulated with a saturating concentration of pheromone shows various
dynamic patterns depending on the cell cycle stage. In order to see how these patterns evolve
at intermediate pheromone concentrations, we performed the cluster analysis described in the
paragraph 3.2.2 on the experiments shown in figure 3.12.B. Independently on the concentration
used to stimulate the cells, we found the four clusters described in figure 3.8 and 3.10. Except
for the G1-locked cluster, the dynamic MAPK activity signal shows a similar trend at all tested
concentrations. However, we observed a reduction of the signal amplitude as the pheromone
concentration drops (figure 3.13). This suggests that the MAPK can respond in a dose-dependent
manner to a range of pheromone concentrations independently on the cell cycle phase. Thus,
the cell cycle regulates the activation capacity of the mating MAPK signalling cascade, but
not its sensitivity to a range of pheromone concentrations. The G1-locked cluster shows a slow
signal decrease at intermediate α-factor concentrations. This drop cannot be due to pheromone
degradation as cells do not express the Bar1 protease. Negative feedback loop mechanisms
acting on the signalling cascade were previously described and may explain such MAPK activity
degradation [136, 48, 77, 127].
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Figure 3.13.: MAPK activity level is pheromone dose-dependent in all phases of the cell cycle.
Experiments from figure 3.12.B are analysed using the clustering strategy described
in the section 3.2.2. Each line is the result of the mean of at least three replicates’
medians at a given α-factor concentration. Error bars are standard deviations.
In the paragraph 3.2.2, we briefly mention a population of cells that transits through G1
during the time-lapse experiment. When exposed to a saturating concentration of pheromone,
this cluster exhibits a noisy dynamic Cdk and MAPK activity 3.2.2. However, this noise is
decreasing at intermediate α-factor concentrations. In addition, we observe that the MAPK
activity of cells in this cluster never exceeds 1.1, while in G1 the MAPK activity can reach 1.6
(figure 3.14.A). This last observation suggests that cells transit through G1 because the MAPK
in not enough activated to block the cell cycle progression.
We have shown that the MAPK activation is pheromone concentration-dependent. Knowing
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Figure 3.14.: Clusters cell fraction change depending on pheromone concentration. The dynamic
MAPK activity of cells transiting through G1. Experiments from figure 3.12.B
are analysed using the clustering strategy described in the paragraph3.2.2. Cell
transiting through G1 during the time lapse experiments are identified as they
exhibit a pulsed of Cdk activity. Single cell traces were synchronised as already
described in figure 3.9 for the G1-entry population. The corresponding dynamic
MAPK activity of at least three replicates is averaged and plotted as in figure 3.13.
B Fraction of cells in each cluster depending on the pheromone concentration. Each
cell fraction value is the mean of at least three replicates.
that activation of the mating MAPK leads to cell cycle arrest in G1, we would expect that
the distribution of the cells in each cluster change depending on the α-factor concentration
(figure 3.14.B). As the α-factor concentration increases, the fraction of cells into the G1-locked and
the G1-entry groups increases, while it diminishes for the S-entry and the Through-G1 clusters.
In summary, we observe an enrichment of cells in G1 in a pheromone dose-dependent manner.
Knowing that the mating pathway activation increases with the pheromone concentration, this
two results indicate that the capacity to arrest the cell cycle in G1 is MAPK activity level-
dependent.
MAPK activity level-dependent regulation of the cell cycle commitment. The cell cycle
commitment is defined as the time when cells pass the START checkpoint to enter in S-phase.
In the cell cycle, this check point is positioned where the mating cannot stop the cell cycle
progression. This corresponds to the time before the cyclin Cln1 and Cln2 get expressed [50, 81].
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Figure 3.15.: Dynamic Cdk activity of cells entering in S-phase prior and after stimulation. Cdk
activity of single cells from one replicate of figure 3.13.C is potted as function of
time. An equivalent number of single traces is randomly selected in both conditions.
The pheromone dose-dependent accumulation of cells in G1 that we observe suggests that the
choice between G1 arrest and cell cycle progression can be influenced. To confirm this, we focused
on the CDK activity of single cells in the S-entry cluster and stimulated either with control media
or with saturating concentration of pheromone. The CDK activity of cells stimulated with media
increases in a delayed manner figure 3.15.A. On the opposite, traces of cells stimulated with
1000nM of α-factor exhibit a synchronised accumulation of CDK activity (figure 3.15.B). Knowing
that cells entering in S-phase and stimulated with saturating concentration of pheromone can
still activate the mating pathway (figure 3.13.C), we can hypothesize that, after reaching a given
CDK activity threshold, the mating pathway is not strong enough to promote the arrest in G1.
In order to see whether this CDK threshold changes depending on the pheromone concentra-
tion, we extracted the CDK activity prior stimulation (Initial CDK activity) from each single cell
entering in S-phase and used boxplots to observe the distribution of these values depending on
the α-factor concentration. The dispersion of the initial CDK values decreases while the median
value increases with the pheromone concentration. The replicate medians follow the same trend
as the median of the replicates used to produce the boxplots (figure 3.16.A). Consequently, the
level of CDK activity required to enter in S-phase changes depending on the activity level of the
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Figure 3.16.: Maximum CDK activity required to commit to cell cycle. A. Basal CDK activity
depending on the pheromone concentration. Initial CDK activity is defined as
the average CDK activity prior stimulation. The distribution of the initial CDK
activity of S-entry cells from one replicate of figure 3.13.C is plotted as boxplot.
The additional dots correspond to the median initial CDK activity of all replicates
at a given concentration. B. CDK activity of cells attempting to enter in S. CDK
activity of the G1-locked cells from the 1000nM replicates are combined. The
“Attempt S-entry” group is defined as the cells that belong to the G1-locked cluster
from figure 3.13.C and have an initial CDK activity above 0.35. The “G1-locked”
cluster contains cells from the G1-locked cluster shown in figure 3.13.C and an
initial CDK activity below 0.35. The “S-entry” cluster contains cells from the S-
entry cluster shown in figure 3.13.C. The corresponding dynamic CDK activity of
these three groups are averaged and plotted. Four single cell traces are plotted to
support the relevancy of the median.
MAPK.
We went further in this analysis and tried to identify cells that attempt to enter in S-phase
but remain blocked in G1. In order to find out whether this population exists, we compared the
initial CDK activity of cells stimulated with 1000nM and belonging to the G1-locked cluster.
We found a small fraction of cells slightly shifted above the major part of the population with
an initial CDK activity higher than 0.35 (data not shown). When focusing on the dynamic
CDK activity of this population, we observe that some traces show a transient increase in CDK
activity right after stimulation, suggesting that cells start to enter in S but fail and remain in
G1 (figure 3.16.B). This fraction of cells failing to enter in S are well identified at 1000nM of
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α-factor. However, the identification appears more challenging at intermediate concentrations,
as the proportion of these cells remains extremely low. This is probably because the arrest in
G1 occurs at low CDK activity levels.
To sum up, we confirmed previous observations showing that the mating pathway is activated
in a pheromone dose-dependent manner. However, we found that the capacity of the cells to be
sensitive to a gradual range of pheromone is conserved in all cell cycle phases. This suggests
that the cell cycle does not interfere with the capacity of the mating pathway to be sensitive to
intermediate concentrations of pheromones.
We also confirmed that the mating pathway inhibits the cell cycle progression by promoting
the arrest in G1. Moreover, our single cell analysis showed that the fraction of cells entering in
S-phase post-stimulation is reduced with the increase of pheromone concentration. This suggests
that CDK and MAPK compete to balance the cell choice toward either the arrest in G1 or the
entry into S. Consequently, the START checkpoint is not defined by a single CDK threshold
value. This threshold can vary and depends on the level of activated MAPK.
3.2.4. Far1 and CDK activities are both required for the mating and the cell
cycle cross-inhibition mechanism
The CKI Far1 is required to arrest cells in G1. We confirmed in the paragraph 3.2.3 that
the mating regulates the cell cycle by promoting the arrest in G1. The molecular basis of this
inhibition was established 25 years ago. Only one protein links the MAPK and the CDK, the
CKI Far1 [88]. Far1 is a specific substrate of the MAPK Fus3 [101]. Once it gets phosphorylated
by the mating MAPK, Far1 binds and inhibits the complex CDK-CLN Cdc28-Cln2 [88, ?]. This
inhibition occurs by preventing the interaction of the CDK-CLN complex with its substrate or
by directly blocking the kinase activity of the Cdc28 [91]. To confirm that Far1 is necessary for
pheromone-dependent inhibition of the cell cycle, we performed the dose-response experiment
shown in figure 3.13 in far1Δ background.
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Figure 3.17.: Pheromone dose-dependent activation of the MAPK in WT and far1Δ. The strain
shown in figure 3.13 was deleted for FAR1 and measured in the same conditions as
the WT in a dose-response experiment. MAPK response is defined as the MAPK
activity reached 5 min post-stimulation minus the average MAPK activity pre-
stimulation, and plotted as function of pheromone concentration. Error bars are
standard deviations of at least three replicates.
The deletion of the gene coding for Far1 should not disturb the activation capacity of the
MAPK module, nor its sensitivity to gradual pheromone concentrations, as this protein is located
downstream of the MAPK in the signalling cascade. To confirm this, we performed time lapse
dose-response experiments with WT and far1Δ strains and extracted the mean MAPK activity
response in the first five minutes post-stimulation. We then plotted this parameter in relation to
the α-factor concentration (figure 3.17). As expected, a similar increase of the MAPK response
is observed for both WT and far1Δ. In addition, the response of G1-locked and S-G2-M cells are
similar in both backgrounds. These results attest that the absence of Far1 has no impact on the
MAPK activation capacity or sensitivity and that inhibition of the mating pathway in S-phase
still occurs.
To determine whether Far1 is required to prevent the cell cycle commitment, we looked at
the fraction of cells in G1 at the end of time lapse experiments. In WT background, this
percentage is increasing in a pheromone dose-dependent manner, ranging from 30% at 0nM up
to 50% at 1000nM. In far1Δ, however, the cell fraction is sustained around 30% at all α-factor
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Figure 3.18.: far1Δ cells do not arrest in G1. The experiment is performed as in figure 3.17.
A. The percentage of cells in G1 at the end of the time lapse movie is plotted as
function of pheromone concentration. Error bars are standard deviations of at least
three replicates. B. The MAPK activity of cells passing through G1 is plotted as
in figure 3.14.A. Solid lines are means of the median of at least three replicates.
Error bars are standard deviations of replicate medians.
concentrations (figure 3.18.A). Consequently, the lack of the CKI Far1 abrogates the capacity
of cells to accumulate in G1 post-stimulation. As we showed that the mating pathway can still
be inhibited in S-phase in far1Δ background, we would expect that the MAPK gets activated
when cells transit through G1. Indeed, we found that the cluster “Pass-through G1” transiently
activates the mating MAPK (figure 3.18.B). Altogether, these results suggest that the CKI Far1
is required to arrest cells in G1 upon pheromone stimulation, but that has no role in the mating
pathway inhibition mechanism in S-G2-M.
CDK activity is required to inhibit the mating pathway. Our single clustering analysis con-
firmed previous studies showing that the mating pathway is inhibited in S-G2-M (3.2.2). Moreover,
it was reported that mating genes and MAPK pathway components are down regulated when
the S-phase Cln1/2 are overexpressed [129, 81]. Overexpression of Cln2 also leads to the hyper-
phosphorylation of the scaffold protein Ste5, that detaches from the plasma membrane and thus
releases the core components of the mating pathway from the pheromone receptor complex[116].
Finally, cells expressing a thermo-sensitive allele of the CDK (Cdc28-ts) show a good rate of
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fusion after release from restrictive temperatures compared to permissive temperatures [100].
This indicates that inhibition of the mating pathway in S-G2-M may require the kinase activity
of the CDK Cdc28.
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Figure 3.19.: Dynamic CDK and MAPK activities after Cdc28-as chemical inhibition. A. Strain
expressing Whi5 and SKARS reporters and an ATP analogue sensitive allele of
Cdc28 (Cdc28-as) is imaged every two minutes for 50 minutes. Cells are stimu-
lated with 100nM α-factor at minute 0 and then with the ATP analogous NAPP1
(10 μM final) or DMSO (0.04% v/v final) 6 min later. MAPK and CDK activ-
ities are plotted for cells starting in S-G2-M phase (mean CDKt<0min <0.5, A),
or entered in S-phase pre-pheromone addition (mean CDKt<0min <0.5 and mean
CDK0min<t<6min >0.5, B).
To confirm that the activity of Cdc28 is required to reduce the mating MAPK activation
capacity, we performed time lapse experiments on a strain expressing a genetically engineered
Cdc28 allele that can be chemically inhibited using the ATP analogue NAPP1. Cells starting in
S-G2-M before stimulation were selected, and dynamic MAPK and CDK activities were plotted
relative to the time of pheromone addition. Cells show a drop of the CDK signal, reaching the
level of G1-locked cells. This decrease occurs in less than five minutes post NAPP1 addition.
The DMSO control experiment shows a sustained high level of CDK activity as expected. This
suggests that the Cdc28-as is quickly inhibited by the ATP analogous, mimicking an entry into
G1. MAPK activity slightly increases in the first six minutes following pheromone addition. This
signal pattern is characteristic of cells in S-G2-M as discussed in figure 3.19.A. However, after
addition of the inhibitor, the MAPK activity signal recovers the level shown by cells locked in
91
3. Mating and cell-cycle cross-inhibition mechanism.
G1, and this in less than 15 minutes. Altogether, these results show that the reduced MAPK
activation capacity of cells in S-G2-M phases can be unlocked through the inhibition of CDK
activity. Thus, the inhibition of the MAPK in S-G2-M stages is regulated by the activity state
of the CDK.
We have shown in figure 3.10.B that cells committed to S-phase entry exhibit a transient
MAPK activity. To find out whether the late inhibition of the MAPK is induced by CDK activity
dependent mechanism, we recovered the data of the experiment performed in figure 3.19.A and
focused on a sub-population of cells that is entering in S-phase after inhibition. We successfully
identified cells that increase their CDK activity prior DMSO/NAPPI addition. This increase
continues after stimulation with DMSO and saturates at the CDK activity level of S-G2-M cells.
Moreover, the MAPK channel shows a transient activity pattern, typical of cells entering in S
phase post pheromone stimulation (figure 3.10.B). This confirms that we succeed in identifying
the cell cycle committed cells using the first 12 minutes of the time lapse only. After NAPP1
addition, however, a sudden drop in CDK activity can be observed. In this condition, we can
also observe that the MAPK inhibition is broken about 5 min after the signal reaches the peak.
Consequently, the MAPK activity inhibition that occurs at the transition between G1 and S can
be prevented by inhibiting the CDK. Therefore, the mechanism triggering the inhibition of the
MAPK activity when cells enter in S is regulated by the activity of the CDK Cdc28.
To sum up we first showed that the Far1 protein is required to arrest cells in G1 and that this
inhibition occurs in a pheromone dose-depend manner. Subsequently, we showed that inhibition
of the mating pathway in S-G2-M phase requires the activity of the CDK Cdc28. The molecular
basis of the MAPK inhibition might involve a direct regulation of protein activity, since the
MAPK activation rate after CDK inhibition release is fast. Altogether, these results suggest
that the mating and the cell cycle cross-inhibition mechanism are ruled by the competition
between the MAPK-dependent activation of Far1 and the CDK activity.
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3.2.5. CDK Inhibition of the mating pathway
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Figure 3.20.: Final MAPK activity at various concentrations of CDK inhibitors. A. Experi-
mental setting. The strain expressing the Cdc28-as allele is imaged for 40 minutes.
CDK is inhibited with different concentrations of NAPPI at time 0 min for 20 min-
utes. α-Factor is then added at saturating concentration (750nM final) and cells
are imaged for 15 additional minutes. B. Dynamic CDK and MAPK activities of
cells starting in S-phase at two extreme NAPPI concentrations. Curves show the
resulting cells that are stimulated with NAPPI at 3000 nM (filled line) and 0 nM
(dotted line). Lines correspond to the median value at each time point and areas
correspond to 25-75% percentiles. C. Correlation between final MAPK and final
CDK. MAPK and CDK activity levels in the last five minutes of the time lapse
are extracted for each individual cell, averaged by calculating the median and com-
pared using a scatter plot. The fitting to a polynomial function is performed on
the experiments from 100nM to 3000nM NAPPI (black line).
MAPK activation capacity is correlated with CDK-activity . We showed that the cell cy-
cle down regulates the MAPK activity during the S-G2-M-phases in a CDK activity-dependent
manner (paragraph 3.2.4). In order to determine whether this inhibition mechanism is correlated
with the activity in a dose-dependent manner, we set an experiment in which the CDK activity is
artificially controlled. Therefore, the Cdc28-as strain was first inhibited with NAPP1, until the
CDK activity reached a desired signal, and then cells were stimulated with saturating concen-
tration of pheromone. For the analysis, we extracted the MAPK and CDK activities obtained in
the last five minutes of the time lapse (25-35 min, Final MAPK and Final CDK, figure 3.20.B.)
Note that the MAPK activity level reached at 3000 nM NAPPI corresponds to the level observed
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for the G1-locked cluster figure 3.20.B. This confirms that NAPPI releases the MAPK from the
CDK-dependent inhibition.
To further determine whether the MAPK activation capacity is linked to a precise CDK
activity value, we compared the Final MAPK and the Final CDK obtained at various inhibitor
concentrations. Overall, these two parameters fit very well to a 2nd order equation (figure 3.20.C).
Altogether, this steady-state analysis shows that the inhibition of the mating pathway is CDK
activity level-dependent.
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Figure 3.21.: Dynamic MAPK activity estimation from CDK activity. A. Model and MAPK
activity fit after CDK inhibition. Dynamic CDK and MAPK activities from one
replicate of the assay described in figure 3.19 are plotted. CDK activity of cells
starting in S-phase is used as input for a model based on the equations obtained
from figure 3.20 (See Appendix B). Solutions of the equations define an estimation
of the corresponding MAPK activity for each single cell at each time point. The
modelled MAPK activity values are averaged using medians and plotted in the same
y-axis as the measured experimental MAPK activity. B. The model fits with the
MAPK activity for cells entering in G1. Strain from A. is imaged as in figure 3.10
without performing any CDK inhibition. Cells are stimulated at time point 0
with 750nM α-factor (final concentration). Dynamic MAPK and CDK activities
of cells entering in G1 are extracted, synchronised and plotted. MAPK activity is
estimated as in panel A and the corresponding median values are plotted.
Modelling of the MAPK activity inhibition mechanism. The NAPPI dose-response experi-
ment we previously performed shows that the MAPK activity depends on the CDK activity. As
these conclusions are based on steady-state experiments, we now ask whether this relationship
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is conserved in a dynamic system. To answer this question, we used the result from the dose-
response experiment and developed a simple model that estimates the MAPK activity based
on the CDK values (Appendix B). Modelled and real dynamic MAPK activities were first com-
pared in conditions where the CDK is inhibited post pheromone treatment (figure 3.21.A). After
pheromone addition, the real MAPK activity recorded for cells starting in S-phase slightly in-
creases up to the level reached in S-G2-M. During CDK inhibition, the MAPK activity increases
for 10 min and stabilises at the level observed for the G1-locked cells. The MAPK activity signal
of the model fits well with the experimental data. Thus, the model confirms the MAPK and
CDK activity correlation in a dynamic system as well.
We then applied our model to a situation in which the CDK activity drops naturally: the
G1-entry transition phase. We performed classical time lapse movies on the Cdc28-as strain.
Using the model, we then estimated the MAPK activity of cells entering in G1 using their CDK
activity values. While the estimated signal increases during the CDK signal degradation, the real
MAPK activity signal first shows a little transient degradation and then increases again to reach
the same steady-state value as the model. We thus conclude that different mechanisms regulate
the MAPK pathway in S-G2-M and during G1-entry. Moreover, these various mechanisms might
be deferentially sensitive to the CDK activity.
To sum up, by controlling the activity level of the CDK and observing the corresponding
MAPK response, we found that the cell cycle inhibits the mating pathway in a Cdc28 activity
dose-dependent manner. The analysis performed in steady-states conditions enabled us to estab-
lish a simple model, which estimates the mating pathway activation capacity relative to a given
CDK activity level. In conditions where the CDK is inhibited, the model fits well the experi-
mental data, but cannot explain the dynamic activation of the MAPK during G1 entry. Thus we
can hypothesise that the cell cycle regulates the mating pathway through multiple mechanisms.
3.2.6. Molecular mechanism of mating inhibition in S-G2-M.
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Figure 3.22.: A. Current model of the mating and cell cycle cross-inhibition mechanism. B.
Schematic linear representation of the structure of Ste5 scaffold protein and the
variant used in the study (adapted from Pope, P. A. & al [91]). B. The Ste58A
variant is obtained by replacing the phosphorylated Serine/Tyrosine surrounding
the PM domain by the Alanine (position: 4,11, 29,43, 69, 71, 81, 102). The Ste5ND
variant is obtained by replacing the LLPP motif at position 278 by a stretch of four
Alanines. Both alleles replace the original STE5 chromosomal copy, and they are
thus expressed under the original promoter. In addition, the BAR1 protease gene
is deleted, in order to avoid early MAPK signal degradation.
The Ste5 scaffold protein is regulated during the cell cycle progression. Our previous analy-
sis confirmed that Cdc28 activity is required to inhibit the mating pathway in S-G2-M. However,
we also showed that the CDK may regulate the MAPK through multiple intermediates. The
current model states that, in mating condition, the Ste5 scaffold protein binds to the protein
Gβγ dimer, so as to promotes the recruitment of the core components of the MAPK pathway
at the membrane [116, 131, 119, 93]. Ste11 is relocated in proximity of the membrane-anchored
Ste20 and the cascade of phosphorylation can start [7] (figure 3.22.A). In 2007, Peter Pryciak and
co-workers established that the CDK, in complex with the cyclin Cln2, regulates the localisation
of the Ste5 scaffold protein [116]. Indeed, Ste5 possesses a N-terminus plasma membrane inter-
acting domain (PM) that acts in synergy with the Gβγ binding [131] (figure 3.22.A-B). In G1,
Ste5 PM domain is bound to the membrane. In S-phase, however, the CDK-CLN complex phos-
phorylates the serine and tyrosine surrounding Ste5 PM domain, promoting the detachment of
the signalling components from the membrane(figure 3.22.B). Thus, signal transduction through
the mating pathway cannot occur anymore.
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Figure 3.23.: MAPK activity response in mutants expressing non-phosphorylatable Ste5. The
dose-response experiment from figure 3.13 is reproduced on strains expressing Ste5,
Ste58A or Ste5ND alleles. A. Dynamic MAPK activity of G1-locked and S-G2-M
cells. Cells were stimulated with 1 μM α-factor at time 0. B. Single cell MAPK re-
sponses following stimulation are calculated and plotted as in figure 3.17.A. Values
correspond to the means of at least three replicates and error bars are standard
deviations.
Although this model, explaining how the cell cycle regulates the mating pathway, is well ac-
cepted, no studies confirmed it at the single cell level. For this reason, we performed dose-response
experiments as in figure 3.13 on strains expressing two alleles of Ste5 previously described
[13, 116]: a CDK non-phosphorylatable mutant (Ste58A) and a cyclin non-docking (Ste5ND)
mutant [131, 91, 90, 14]. We compared MAPK activity reached by cells expressing the Ste5
alleles when they are either in G1 or in S-G2-M. Cells expressing the Ste5 or the Ste5ND alleles
show similar dynamic MAPK activities when they are in G1 phase (figure 3.23.A). However,
the strain expressing the Ste5ND exhibits, during the S-phase, a higher and sustained MAPK
activity compared to the strain expressing the WT allele. The same response is observed in cells
expressing the Ste58A (data not shown). This confirms the results from Strickfaden & al, 2007
[116], suggesting an improved activation of the mating pathway in S-phase, when Ste5 cannot be
phosphorylated. Surprisingly, the MAPK activity of S-G2-M clusters from both Ste5 mutants
does not stabilise at the level of the G1-locked clusters. We confirmed this difference by the
comparison of the S-G2-M and G1-locked MAPK response at intermediate pheromone concen-
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trations (figure 3.24.B). At all tested concentrations, Ste5 mutants display a weaker ability to
signal in S-G2-M than in G1.
Altogether, these results suggest that the cell cycle regulates the mating through the regula-
tion of the phosphorylation state of the scaffold protein Ste5. However, as mutant expressing
non-phosphorylatable Ste5 alleles still show reduced MAPK in S-G2-M phases compared to G1
suggesting that additional mechanism occur to inhibit the mating pathway in this cell cycle
stage.
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Figure 3.24.: MAPK activation after CDK inhibition in the Ste5ND strain. A. Cdc28-as strain
expressing the Ste5ND and deleted for BAR1 is imaged and analysed as in fig-
ure 3.21.A. The curve represents MAPK and CDK activities of cells in S-phase
in the beginning of the experiment. B. The DMSO control experiment from A
is analysed as in figure 3.21. Curve represent the CDK and MAPK signal of cell
entering in G1 post pheromone addition. For both panel, filled and dotted lines
correspond to medians of single cells traces.
The inhibition of Ste5 is CDK activity-dependent. The Ste5 phosphorylation by the CDK
is not sufficient to explain a complete inhibition of the mating pathway in S-G2-M phases. In
order to determine whether the remaining mechanisms are CDK activity dependent, we tried to
observe whether S-G2-M cells expressing Ste5ND alleles reach the maximum MAPK activity after
Cdc28-as inhibition with NAPP1(figure 3.24). We focused our analysis on the Ste5ND because
the Ste58A possesses unmutated potential phosphorylation sites. In the ND allele, however,
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the Cln2 binding site mutation may totally abrogates the phosphorylation by the Cdc28-Cln2
complex. Cell starting in S-phase prior pheromone addition activates the mating pathway at
intermediate level. As expected, the intermediate MAPK activity reached in this mutant is
higher compared to the one observed in the WT (Ste5 ND : 1.2, WT: 1, compare figure 3.24.A
with figure 3.21.A). After CDK inhibition, the MAPK activity increases and stabilises at the
level of the G1-locked cluster. This suggests that additional mechanism(s) of inhibition of the
mating pathway require the CDK activity. These results confirm that Ste5 phosphorylation only
partially explains the inhibition exerted by the CDK and that additional CDK activity-dependent
mechanisms are still required.
We observe in figure 3.21.B that the MAPK is transiently inhibited just before completing
the cell cycle. To determine whether the phosphorylation of Ste5 contributes to this signalling
cascade down regulation, we recovered the data from the DMSO control experiment used in
figure 3.24.A, and observed how the MAPK is activated while cells enter in G1 (figure 3.24.B).
The model does not support the data at high CDK activity level (before G1 entry). Moreover,
both modelled and experimental MAPK signals are delayed when the CDK activity drops, and
the MAPK negative overshoot observed during CDK signal degradation is even amplified. This
last result suggests that an independent and stronger inhibition of the mating pathway occurs
at the transition between S-G2-M and G1 phases. Altogether, these results suggest that the
Ste5 phosphorylation driven by the CDK in S-G2-M phases contributes to inhibit the mating
pathway, but it is not sufficient to completely abolish it.
Cdc28 does not regulate the mating through the MAP2K or the MAP4K We previously
concluded that the CDK might target multiple components to inhibit the mating in S-phase. In
this section, we will investigate two potential targets of the CDK. As suggested by Ammerer and
colleagues, the regulation of the cell cycle can happen through Ste11 or downstream components
(Ste7, Fus3) [129]. We first tested the role of the MAP2K Ste7. This kinase is essential for signal
transduction, since a deletion of the encoding gene causes the cells to be completely insensitive to
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Figure 3.25.: Potential inhibition of the MAPK through Ste7. A. The Ste76A variant is obtained
by replacing the serine/tyrosine phophorylation sites by an alanine (Amino acid
numbers: 105, 130, 167, 116, 137, 149). The Ste7ND variant is obtained by re-
placing the region coding for the SISLPPL motif at protein position 156 with a
sequence coding for alanines. Both alleles replace the original WT copy of STE7.
Note that strains express also the Ste5ND allele. Alleles are thus expressed under
the STE7 native promoter. B. Single cell MAPK responses after stimulation are
calculated and plotted as in figure 3.17.A. Values correspond to means of at least
three experimental replicates and error bars represent standard deviation.
pheromones[19]. The MAPK Fus3 is also known to regulate the MAP2K by phosphorylation, so
as to reduce the signalling cascade sensitivity [35]. Moreover, Ste7 is known to be ubiquitinated
in a pheromone-, cell cycle- and Ste11- (MAP3K) dependent manner [?, 127]. Finally, when
analysing the sequence of Ste7, we found a LPPL motif [13] that ressembles to the typical
Cln1/2 docking site found in Ste5. In order to see whether the cell cycle regulates the mating
pathway through Ste7 in S-phase, we constructed strains expressing variants of this protein. Note
that these strains also express the Ste5ND allele, in order to observe only the potential effect
of the CDK on Ste7. In the first tested allele (Ste76A), all the phosphorylation sites located
outside the kinase domain are replaced by an alanine. The second Ste7 variant (Ste7ND) is
mutated for the potential Cln1/2 DS (LPPL motif, figure 3.25.A). We then performed time
lapse experiments and analysis as described in figure 3.23.B. We do not observe any difference
of MAPK activity response between the WT background and the strains expressing the Ste7
variants (figure 3.25). Thus, the cell cycle does not regulate the mating pathway in S-G2-M
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phases through a CDK-dependent phosphorylation of Ste7.
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Figure 3.26.: Inhibition of the MAPK through Ste20. A. The Ste2011A variant is obtained by
replacing the serine/tyrosine phophorylation sites by an alanine (positions: 269,
418, 423, 492, 502, 512, 517, 547, 555, 562, 573). The Ste20ND variant is obtained
by replacing the coding sequences of the SLDDPIQF and the PLPPIPP motifs at
protein positions 87 and 535 with sequences of same length coding for alanines.
Both alleles are inserted into the strain expressing the Ste5ND, at the original
STE20 chromosomal locus. STE20 variants are thus expressed under their native
promoter. B. Single cell MAPK responses following stimulation are calculated and
plotted as in figure 3.17. Values correspond to means of at least three experiments
and error bars represent standard deviation.
It was demonstrated that a strain with inhibited Cdc42 or its master regulator Cdc24 does not
activate the mating during the S-phase, suggesting that the cell cycle target a mating pathway
component located downstram of Cdc42 [22]. Ste20 PAK-like kinase (MAP4K) might be a
good target for cell cycle regulation. Its phosphorylation, localisation and activity are regulated
in a cell cycle-dependent manner [66, 13]. Ste20 contains a well-known Cln2 DS at the N-
terminus of the protein, that enables a direct phosphorylation of the protein by the CDK [13]
(figure 3.26). We also found a second potential DS motif surrounded by eight phosphorylation
sites. Phosphorylation of these sites is thought to open the protein, so that the CRIB domain of
Ste20 can bind the active GTP bound form of Cdc42. This open conformation is also thought to
be important to promote signal transduction through the mating pathway [64]. We tested the
response to pheromone of strains expressing Ste20 variants mutated for their phosphorylation
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sites, for both Cln DS, or with a CRIB domain deleted allele (figure 3.26). Note that these strains
also express the Ste5ND. In all the tested constructs, G1-locked cells activate much more the
MAPK than the S-G2-M cells, as in the WT background. Thus, the cell cycle does not regulate
the mating pathway through Ste20.
To sum up we confirmed in this section that Ste5 scaffold protein is an entry point for the
cell cycle to regulate the mating pathway. The CDK-CLN complex phosphorylates the protein
and promotes the detachment of the Ste5-Ste11-Ste7-Fus3 complex from the membrane [116].
However, we found that this model is not sufficient to explain the MAPK inhibition in S-G2-
M phases. We concluded that additionnal mechanism(s) act in addition to the Ste5-dependent
mechanism. We tested two potential CDK targets, the PAK-like kinase Ste20, also known
at the MAP4K, and the MAP2K Ste7, by expressing phosphorylation sites and using Cln1/2
DS derivative mutants. However, none of these alleles have improved S-G2-M MAPK activity
compared to strains expressing the WT allele. Thus, the mechanism acting in parallel with the
CDK-dependent Ste5 phosphorylation has still to be uncovered.
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Cell fate decision making: mate or divide. Using combination of synthetic biology and live
fluorescence microscopy, we accurately monitored the dynamic kinase activity of both mating
MAPKs, Fus3 and Kss1, after pheromone stimulation and in function of the cell cycle progression.
With this strategy we confirmed that the activation capability of the mating pathway is maximal
during G1. This result supports the fact that in mating assays, two opposite mating types
undergo fusion only during this cell cycle phase. Biologically, this makes sense since cells contain
one copy of each chromosome and the polarisation machinery can be fully exploited to shmoo
toward the partner. Therefore, this process implicates an arrest of the cell cycle progression in
order to allow the starting a new transcriptional program and the polarisation.
We monitored the cell cycle arrest in G1 upon stimulation with pheromones and infered that
the START checkpoint is not defined only by the CDK activity threshold [50, 81]. Indeed, we
demonstrated that the arrest in G1 is also MAPK activity dose dependent. Thus CDK and
MAPK compete to drive the cell choice either toward arrest in G1 or cell cycle commitment.
We attempted to quantify this relationship between CDK and MAPK activities to be able to
anticipate the cell choice. However, we were limited by the fact that daughter cells can stay
longer in G1 independently on the MAPK activity level [26, 25]]. Consequently, it is difficult
to identify mating-induced G1 arrest events. This issue could be solved by imaging for a longer
period prior stimulation and focusing the analysis on cells that enter in G1 prior pheromone
addition. Lineage tracing methods could also be used in order to separate mother cells from
daughter cells [126, 102].
The delay between cell cycle commitment and MAPK activity inhibition rises another im-
portant question: how much active Far1 is required to arrest the cell cycle? This question can
be partially addressed in cln3Δ background since this cyclin was reported to be responsible for
cell cycle dependent degradation of Far1 [53]. Alternatively, we could think about constitutively
express a stable version of Far1 [72]. In this condition, we would abrogate the cell cycle depen-
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dent regulation of Far1 and the arrest would be only the downstream consequence of the MAPK
activation. Then, by expressing the CKI with constitutive promoters of increasing strength, we
would be able to define how much Far1 is required to block the cell cycle progression.
Another possibility would consist in correlating the Far1 expression and degradation with the
capacity of commitment to cell cycle. Tagging Far1 with a fluorescent protein (FP) is not a
good option, since the signal would be subjected to artifacts mostly due to the FP maturation
time. This problem can be bypassed using the dPSTR technology we developed in our lab [3].
The dPSTR would be fused to the FAR1 promoter and supplemented with the fragment of
CKI responsible for its cell cycle dependent degradation. In combination with the Whi5 marker,
Far1 protein levels could be monitored across the cell cycle phases by reporting the nuclear
accumulation of the dPSTR into the nucleus prior and after pheromone treatment.
Inhibition of the mating pathway in S and G2 phases Our study showed that inhibition of
the mating pathway in S-G2-M phases is CDK activity dose-dependent and confirmed that one
target of the CDK Cdc28 is the Ste5 scaffold protein. However, we realised that the molecular
mechanism proposed by the group of Pryciak is not sufficient to explain how the MAPK is
inhibited in S-G2-M phases[116]. Thus, other mechanisms have to be uncovered.
Two articles have narrowed down the number of potential targets of the cell cycle at proteins
located either downstream of Cdc42 in the signaling cascade [22], or downstream/in parallel
of Ste11. We thus attempted, without success, to verify a potential direct regulation of Ste20
(MAP4K) and Ste7 (MAP2K) by Cdc28. Another potential target currently under investigation
is the adaptor protein Ste50. This scaffold links the MAP4Ks Ste20 and Ste11. Some mutants
of Ste50 protein were shown to differentially activate the mating pathway compared to WT[56].
Moreover, this protein contributes to the crosstalk between pathways and contains a multitude of
potential phosphorylation sites targeted by the MAPKs Fus3, Kss1 and Hog1 [134]. For example,
Hog1-dependent phosphorylation in hyper-osmotic stress condition dampens the mating pathway
[76]. Consequently, Ste50 is a key component required to maintain MAPK pathway specificity.
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Therefore, this protein could be an entry point to regulate the mating pathway in S-G2-M phases.
Finally, we cannot reject the hypothesis that Ste5 can be regulated through other paths. We
tested the hypothesis of the membrane detachment through the phosphorylation of the Ste5 PM
domain [93, 116, 119], but other putative phosphorylation sites and a second cyclin docking site
are located close to domains known to interact with the MAP3K, the MAP2K and the MAPK.
We observed that in S-G2 the MAPK activity is reduced and not completely abrogated. This
slight activation of the mating pathway may explain why some groups have reported that the
signalling cascade can be activated in G2[19]. We can imagine that this low activity may con-
tribute to prepare the cells for mating when they enter in G1. Preliminary results showed that
some promoters involved in mating, such as the PFAR1 or PAGA1 are induced in S-G2, although
not as efficiently as in G1. This would mean that mating genes respond differentially depending
on the level of activated MAPK. Overall, investigation of the regulation of mating dependent
genes in function of the cell cycle stages opens a wide possibility of further investigations, and
this thank to our strategy.
Transient MAPK inhibition during G1 entry Finally, our data suggest that the MAPK is down-
regulated during the CDK signal degradation at G1 entry. It was shown that CDK activity must
drop to enable an exit from the M-phase [97]. Consequently, we hypothesise that the transient
inhibition of the mating pathway occurs during the M-phase. Our results suggest that the
MAPK, or one or multiple upstream signalling cascade components, are transiently inhibited at
G1 entry and this independently on the Ste5 phosphorylation.
Although the regulation of the mitosis in budding yeast is well documented, it remains difficult
to make a direct link between the mating pathway components and regulators of the M-phase. It
was reported that transcription of many MAPK pathway component genes are regulated in a cell
cycle dependent manner [80]. However, the transient inhibition occurs in less than 20 minutes,
which is fast for a transcriptional regulation.
Two other components might make the link between the M-phase and the mating. These are
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the Ste20 PAK-like kinase and the scaffold protein Bem1. Both are known to localise at the
septum[69]. In mating condition, Bem1 is implicated in shmoo formation but is not required for
MAPK activation [17]. On the contrary, Ste20 has a clear role in the mating pathway. We tested
various expressing Ste20 alleles but we did not observe any MAPK activity signal difference
compared to WT (data not shown). Considering this, the MAP4K might not be implicated in
the pathway inhibition during the M-phase and the potential targets might be either downstream
to it or part of the receptor branch.
Following this last idea, the α-subunit of the G-protein, Gpa1, could be a interesting candidate.
The phosphorylation of this protein is promoted in G2-M by the Elm1 kinase[61] and is poly-
ubiquitinatinated in G1 [125]. The Elm1 kinase is a well know regulator of cell morphology and is
located at the bud neck. Moreover, a deletion of this protein leads to filamentous morphology that
can be compensated by a Cdc28 mutant that lacks some functional phosphorylation sites[32]. To
conclude, Gpa1 might be a good target for the cell cycle to control the mating pathway activity
in M-phase.
The last hypothesis we can draw is that the transient inhibition is not induced by a mechanism
that specifically target the mating pathway. Indeed, we mention previously that the CDK activity
must drop to exit M-phase [97]. To achieve this, a huge pulse of active phosphatases (Cdc14 and
PP2A) is released and inhibits directly the CDK [52] and its substrate. Thus, we can suggest
that these phosphatase inhibits the mating pathway through unspecific dephosphorylation of the
signalling cascade components.
3.4. Conclusion
In this chapter, we described a single cell analysis of the mating and cell cycle cross-inhibition
mechanism. By combining synthetic biology with live single cell imaging and computational data
analysis, we succeeded in measuring in each individual cell the kinase activity of the cell cycle
regulator Cdc28 and the mating pathway MAPKs Fus3 and Kss1 . Our strategy enabled to iden-
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tify four main MAPK dynamic activity patterns linked to cell cycle position. We confirmed that
the mating pathway induces cell cycle arrest in G1 through the Far1 CKI and that the cell cycle
inhibits the mating pathway through the phosphorylation of the Ste5 scaffold protein. However,
we found that additional uncovered CDK activity dependent mechanisms act in addition to the
Ste5 phosphorylation in S-G2-M phases. Finally, we found that MAPKs are strongly down regu-
lated during the transition between S-G2-M and G1 phases, suggesting that another mechanism
induces the inhibition of the mating pathway independently on Ste5 phosphorylation. Further
investigations will have to uncover these parallel mechanisms and test their relevance on mating
efficiency.
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SKARS Cell-to-cell variability has become an important field of investigation during this last
decade. Indeed, an isogenic population can exhibit a either a uniform response or a heterogen-
eous behavior from cell-to-cell. These observations have important implications in the signal
transduction field, as the cell fate is the result of the processing of intra/extracellular cues by
signalling cascades. Signal processing by signalling cascades is defined by a sequence of reactions
driven by molecular mechanisms specific to the current physiological state of the cell. Dynamic
single cell analysis of signalling cascade activity is thus required to define the molecular processes
leading to a given cell fate. FACS and single cell mass spectrometry show only snapshots of the
state of a cell, while fluorescent based reporters are mostly limited by the maturation time of
the fluorophore. Thus, despite important technical progresses, investigating the activity state of
signalling cascades at the single cell level remains difficult.
In the first chapter, we described a new approach based on a synthetic fluorescent biosensor
that can act at the same time scale as the signal transduction and reports the activity state of
a kinase from a signalling cascade. This synthetic fluorescent biosensor, that we called SKARS,
is composed of three domains: a docking site (DS), a nuclear localization sequence (NLS) and
a fluorescent protein (FP). The DS enables a specific interaction with the kinase of interest and
the NLS promotes the active transport of the sensor into the nucleus. Once activated, the kinase
inhibits the NLS by phosphorylation and promotes the cytoplasmic accumulation of the sensor.
Thank to time lapse microscopy, we can deduce the dynamic activity of this kinase by calculating
the ratio of fluorescence intensity between the nucleus and the cytoplasm. Bioinformatic analysis
allow to perform this measurement in hundreds of individual cells, enabling us to probe the
activity state of the signalling cascade upstreamfrom the measured kinase.
The first version of the SKARS was built to measure the activity of the mating MAPKs Fus3
and Kss1. Then, we adapted the SKARS to probe the MAPK MPk1 from the CWI pathway. We
easily achieved this by replacing the original interaction domain by the DS of the Mpk1 upstream
regulator, Mkk2. This shows that only minor changes in the structure of SKARS are required
to measure another MAPK. Although we designed sensors to measure the activity of various
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MAPK, one can envision to use the SKARS technology to measure other kinases. The only
limit consists in finding a regulator or a substrate which contain a very well-defined interaction
domain. If no interaction can be found, a possible solution would be to use interacting peptides to
artificially promote the interaction of the biosensor with the kinase [122]. For instance, SynZips
are hetero-specific synthetic coiled-coil peptides that work by pairs and specifically interact with
each other. The idea would consist in using one SinZIP to tag the kinase of interest and replace
the SKARS DS by a complementary peptide. Overall, this strategy would enable to enlarge the
spectrum of measurable kinases.
The straightforward structure of SKARS also enables to overcome the species barriers. In-
deed, NLS signals are reported to be functional in broad number of organisms, like mammalian
cells. Moreover, MAPK phosphorylation sites are also widely conserved. We recently developed
SKARS for three MAPK from mammalian cells, ERK, JNK and p38. For this, we used their
known upstream regulator DS that we inserted in our yeast sensor. In fact, similar MAPK sensors
has been designed during the SKARS developpement. The KTR biosensor from the Corvet lab
have a very similar structure, although it possesses an additional nuclear export signal [99, 138].
We are currently comparing the range of sensitivity of the KTR and SKARS. The preliminary
result of Min Ma, a Post-Doc from our lab, suggest that the KTR saturates its signal at a lower
level than SKARS, meaning that our design seems to better translate higher kinase activity level.
Consequently, our SKARS technology might be a good alternative to KTR.
Application The SKARS technology offers many possibilities of application. In this study, we
used this bio-reporter to record the activity of mating MAPK following exogenous pheromone
stimulation. The same kind of investigation can be done with mammalian cells in the context
of drug discovery for cancer therapy. Indeed, a drug can be tested for its effect on MAPK
activation and, at the same time, the downstream behaviour can be observed. We can also
imagine to observe the emergence of cancer cell resistance to some drugs and try to correlate it
with a particular MAPK activity signal pattern.
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The MAPK activity signature that is recorded by SKARS provides interesting information
about the kinetics of signal transduction through signalling cascades. However, the measured
kinase activity pattern often results from the combination of multiple inputs, since signalling
pathway are all interconnected. Thus, in some cases, the signalling cascade must be isolated to
describe its various kinetics properties. Recent studies have described optogenetic systems such
as the CIBN/CRY2 from Arabidopsis thaliana [60] or the photo-dissociable tetrameric green
fluorescent protein Dronpa145N[138], that allows a controlled activation of a pathway. These
methods consist on promoting the oligomerisation of two proteins by illuminating cells at a
precise wave length. Using this technique, the Michael Lin lab has artificially generated various
Akt kinase activity patterns and correlated this with specific cell behaviours. On the other
hand, the group of Takeaki Ozawa combined the SKARS homologue (KTR) with his optogenetic
system, and uncovered a direct and rapid inhibitory feedback loop from ERK to MEK1.
These last examples illustrate a second straightforward property of our biosensors. The SKARS
technology can be combined with other biosensors. The combination of multiple sensors can
be extremely useful in the context of the study of cross-talks between signalling cascades. In
the chapter two, we presented an experimental setting where the yeast mating MAPK and
the cell cycle progression were both probed at the same time using a SKARS sensor and the
Whi5 transcription factor respectively. Based on our quantitative measurements, we confirmed
that the two physiological processes are interconnected at the level of signalling cascades. The
mating pathway promotes the cell cycle arrest in G1 by activating the Far1 CKI, while the
CDK Cdc28 inhibits the MAPK during the S-G2-M cell cycle phases. Our single cell analysis
confirmed that the CDK targets the Ste5 scaffold protein by phosphorylating its PM domain
[116]. However, we revealed that other mechanisms occur in S-G2 phases. In M-phase, the MAPK
activity seems to be regulated through a mechanism that could not require the phosphorylation of
Ste5. Consequently, parallel measurements of multiple kinase activities in live single cell enable
to extract high resolution data, allowing to understand how signalling cascades cross-interact
dynamically.
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We chose to investigate the cross-talk between mating and cell cycle by combining a natural
CDK sensor with the SKARS. Other proteins, such as as the MAPK Hog1 in yeast, or the
mammalian transcription factors NF-κB, are known to change their sub-cellular localisation
depending on the activation of MAPKs. However, not all MAPKs, MAPKs’ substrates and
regulators exhibit such a behaviour. In Chapter 1, we proved that this problem can be solved by
combining multiple SKARSs tagged with different fluorescent proteins into the same yeast cell.
Preliminary data from Min Ma, suggest that this strategy can also be applied in mammalian
cells as well (also supported by data from the Corvert Lab[99]).
Although the combination of SKARS sensors is an interesting feature that can be applied to
study the cross-talks between signalling cascades, the biosensor is also fully compatible with other
synthetic bio-reporters. Indeed, Delphine Aymoz, a PhD student in our lab, has developed the
synthetic translational reporter dPSTR, that is fully compatible with the SKARS technology
[3]. In the context of the response to pheromones, we can imagine to correlate the MAPK
activity with the induction of particular genes. Combined with the Whi5 marker, this gene
regulation can be monitored in parallel with MAPK activity and during the cell cycle progression.
Because of technical issues due to overlapping of FP emission spectrum, not enough fluorescent
channel are available to combine these three sensors. One possible solution to counteract this
problem would be to direct the phosphorylation-dependent relocation of the sensor to another
cell compartment. Inspired from the work of Nadim Mira, a former lab member, we can imagine
a bipartite synthetic protein, with one component constitutively located at the plasma membrane
and a second one that would interact with its partner after being phosphorylated by the MAPK.
In such situation, the MAPK activity is converted in a relocation signal from the cytoplasm to
the plasma membrane. We are currently investigating this in the lab.
The SKARS sensor might be combined with another biosensor that enables to quantify the
number of mRNA molecules using the Ms2 or PP7 phage coat proteins [65, 12]. We can imagine
to observe the number of produced transcripts following the activation of a promoter regulated
by the MAPK. We can also imagine to probe the signalling cascade activity and both the down-
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stream transcriptional and translational responses with the SKARS, our dPSTR and the pp7
system respectively. Using simultaneously these three types of sensors, we would be able to get
fantastic information about how these three cellular processes interact with each other and drive
the cell fate decision in a given environment.
Overall, the synthetic biology field has promoted the emergence of new techniques enabling to
probe key cellular processes in live single cells. The study of single cell behaviour has been limited
for a long time by the capacity to observe the development of the cell in its natural environment.
In the context of mating process study in yeast, we can already observe the fusion process while
extracting the MAPK activity and tracking the cell cycle progression of individual cells. In
mammalian cells, however, this is more complicated, since single cells evolve in a tissue that has
complex structure and composition. This major limitation is about to be broken-down by the
recent progresses done in the microscopy field, that have led to the emergence of new techniques
such as three-dimensions live microscopy or intra-vital microscopy. We strongly believe that
SKARS might play a role in the future investigation based on these techniques. We can imagine
to study the MAPK activity of single cells during the development of model organisms such as
zebrafish (D.rerio) or the nematode C.elegans, or to probe the MAPK activity of cancer cells
directly inside the tumors’ macro-environment. We are currently collaborating to invest this
path.
Conclusions In this thesis we presented a synthetic bio-reporter that allows accurate meas-
urements of signalling cascade activity, dynamically and at the single cell level. The sensor is
actively imported into the nucleus when the signalling cascade kinase is OFF, and accumulates
into the cytoplasm when the kinase is turned ON. This subcellular localisation change is used
as a proxy for kinase activity measurements through the calculation of a ratio of fluorescence
intensity between the nucleus and the cytoplasm. We apply this technique in the context of the
study of the yeast mating MAPK and cell cycle cross-inhibition mechanism and proved that the
current model describing how the cell cycle regulates the mating pathway is incomplete.
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This first example of application of such system led us to conclude that the SKARS can be
applied in numerous fields of research by combining this probe with other bio-reporters. Com-
bination of multiple SKARSs enables to study cross-talk between pathways such as the MAPK
pathways. In addition, the SKARS can also be combined with transcriptional or translational
fluorescent based reporters in order to assess how some promoters would respond to various
dynamic signalling cascade activity patterns.
To conclude, the SKARS synthetic protein is a tool that can be used to comprehend how
individual cells process intra- and extracellular signals and how this leads to a particular cell
fate.
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Strains and plasmids Yeast strains and plasmids are listed in table A.1table A.2. SKARS
plasmids were constructed by cloning the different parts of the sensor into a pRS304 or pRS306
vector backbone [113]. They were expressed from the constitutive promoter PRPS2, cloned using
SacI-HindIII restriction sites. The DS from STE7, FAR1, and MKK2 were amplified either
from yeast genomic DNA or synthesised and subsequently cloned between HindIII and XbaI
sites. To generate the 2xNLS sequence, two oligos were synthetized, annealed, and cloned in
the vector by enzymatic restriction with XbaI and BglII. The fluorescent proteins mCherry,
mCitrineA206K,L221K or CFP were cloned between BglII and XhoI. A CYC1 terminator was
cloned between XhoI and KpnI.
In chapter 3, the sensor and the corrector were assembled by cloning the STE71−33-NLS-NLS-
mCherry or the STE7ND-NLS-NLS-CFP (HindIII-KpnI) sequences downstream the PRPS6b pro-
moter into the pSIVURA (SacI-KpnI) [132]. The plasmid pED141 containing both sensor and
corrector was obtained by cloning the PRPS6b-STE7ND-NLS-NLS-CFP into the second MCS
of pED92 (AatII-SphI). The plasmids were transformed in W303 yeast background bearing a
Hta2-CFP nuclear marker (ySP37) or the Hta2-tdiRFP (yED136).
Genomic deletions were constructed in cells bearing the sensors using KAN or NAT resistance
cassettes [40, 70]. In the chapter 2, Whi5 and Yox1 were tagged with mCitrine using pKT139 plas-
mid [111]. In the chapter 3, Whi5 was tagged with mCitrine using pGTT-mCitrineA206K,L221K
plasmid [132]. Plasmids containing the coding sequence of Ste5, Ste20 and Ste7 were obtained by
amplification of a chromosome fragment spanning from about -100bp (into the promoter) to the
end of the ORF and cloned using PacI-NheI sites into the pGTH-CFP, replacing the fluorescent
protein. Mutated variants were then obtained by replacing a fragment of the gene by a syn-
thesised double-stranded DNA containing the desired mutation. Plasmids were integrated into
the genome of yeast by homologous recombination replacing the NAT or KAN cassettes used to
delete the genes.
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Sample preparation The cells were grown in saturated overnight cultures at 30°C in synthetic
medium (YNB: CYN3801, CSM: DCS0031, ForMedium) . They were diluted in the morning to
OD600 0.05 and grown for at least four hours before starting the experiments. For experiments in
wells, 96-well plates (MGB096-1-2LG, Matrical Bioscience) were coated with a filtered solution
of Concanavalin A (0.5 mg/mL, 17-0450-01, GE Healthcare) for 30 min, rinsed with H2O, and
dried for at least 2 hours. Before the experiment, the cultures were diluted to an OD600 of 0.05,
and briefly sonicated. A volume of 200 μL of culture was loaded into each well. Cells were left
settling 15-45 minutes before imaging. To stimulate the cells, 100 μL of inducing solution was
added to the wells. For α-factor stimulation, 1 μM final concentration. Zymolyase (120491-1,
AMS Biotechnology) stress was applied at 3 U/mL final concentration. To inhibit Fus3as or
Cdc28as (chapter 2, chapter 3), a 25 mM stock solution of NAPPI (A603004, Toronto Research
Chemical) in DMSO was diluted in SD-medium to 40 μM. The solution was added to the wells
to obtain a final working concentration of 10 μM. In control experiments, cells were treated with
DMSO 0.16 % in SD-full.
For the dose-response experiment from figure 2.11, the pheromone stimulation was performed
in Eppendof tubes. Specifically, 200 μL of cell culture was mixed with 100 μL of α-factor to reach
a final concentration between 0 and 1 μM. Immediately after mixing, 200 μL of this suspension
was loaded into a coated 96-well plate. After 15 minutes of incubation, images from ten different
were acquired.
For the hypo-osmotic stress experiment in microfluidic device (figure 2.24.A-B), cells were
grown overnight in SD medium containing 1 M sorbitol, diluted in the same medium to OD600 of
0.05, and grown for at least 4 hours before the beginning of the experiment. Cells were diluted
to an OD600 of 0.25 if necessary, and 200 μL of culture was loaded in a microfluidic chip (Y04C,
CellASIC Corp). SD medium with 1 M sorbitol and containing fluorescein-dextran (D3305,
Invitrogen) 1 μg/mL was added into flow chambers 1 and 2. SD medium with 0.5 M sorbitol and
containing fluorescein-dextran 0.5 μg/mL was added to wells 3 and 4. To allow a rapid switch
between the media, the pressure was set at 3 psi in wells 1 and 2 and at 0.3 psi in wells 3 and
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4. At the desired time, the high and low pressures were inverted to load medium into the cell
imaging chamber.
Microscopy Images were acquired with a fully automated inverted epi-fluorescence microscope
(Ti-Eclipse, Nikon), controlled by Micromanager software [117] and placed in an incubation
chamber set at 30 °C, with a 40× oil objective and appropriate excitation and emission filters.
The excitation was provided by a solid-state light source (SpectraX, Lumencor). The images
were recorded with a sCMOS camera (Flash4.0, Hamamatsu). A motorised XY-stage allowed
recording multiple fields at every time points. CFP (40 ms), RFP (100 ms), and YFP (100 ms
(chapter 2) or 300 ms (chapter 3)) and two brightfield (10 ms) images were recorded at time
intervals between 1 and 5 minutes.
Data analysis Time-lapse movies were analysed with the YeastQuant platform [85] (figure 2.4).
The cell nuclei were segmented by thresholding from CFP images. The contour of the cell around
each detected nucleus was detected using both brightfield images. The cytoplasm object was
obtained by removing the nucleus object expanded by two pixels from the cell object. The nuclei
were tracked across all the frames of the movie. Multiple features of each object were quantified.
Dedicated scripts in Matlab R2016b (The Mathworks) were written to further data analysis.
Only cells tracked from the beginning to the end of the movie were taken into consideration.
In addition, for single cell analysis, a quality control was applied on each trace and only the
traces with low variability in nuclear and cell area, CFP nuclear fluorescence, and RFP cellular
fluorescence were kept for further analysis.
For each cell, the average nuclear intensity in the fluorescent channel corresponding to the
SKARS was divided by the average intensity in the cytoplasm for every time point, in order
to generate the single cell trace. The basal level was calculated as the mean of the three first
time points of the nuclear-to-cytoplasmic ratio. The nuclear-to-cytoplasmic ratio was normalised
by division with the basal level. The final response was calculated as 1 minus the average of
the last three time-points of normalised nuclear-to-cytoplasmic ratio. The initial response and
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the MAPK response were calculated as 1 minus the average of three time-points shortly after
the stimulus (3–5 minutes after α-factor addition). The initial CDK activity was defined as the
average of three time-points shortly before the stimulus (3-6 minutes before α-factor stimulus).
For the Cdc28as NAPP1 dose response experiment, final MAPK and CDK activities were defined
as the average of the time-points after α-factor addition (4-10 minutes after stimulus). All these
quantities are unitless numbers, since they are ratios between fluorescence intensities obtained
from the microscope camera. We used the symbol [–] to represent this lack of units.
Mathematical model In chapter 2, we used the SimBiology toolbox of Matlab (R2014a)
to simulate the model. The details of the reactions implemented and constant rate used are
provided in the Appendix B. To extract the MAPK activity based on the experimental nuclear-
to-cytoplasmic ratio, an equation representing the MAPK activity as a function of time had to
be provided. The parameters of this equation (table B.3) were then optimised to obtain the best
fit of the experimental data. In the chapter 3, simulations of the model was obtained using a
Matlab (R2016b) scripts. Details od the procedure for the modelling are in the Appendix B.
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Table A.1.: Table of strains
Name Genotype Figure
ySP2 W303: MATa leu2-3, 112 trp1-1 can1-100 ura3-1
ade2-1 HIS3-11,15
yED42 HTA2-CFP ura3 :pED45
yED54 HTA2-CFP ura3 :pED45 ste11Δ::NAT
yED53 HTA2-CFP ura3 :pED55
yED51 HTA2-CFP ura3 :pED53
yED52 HTA2-CFP ura3 :pED54
ySP456 HTA2-CFP ura3 :pED45 leu2 :pED198 kss1Δ::KAN
fus3Δ::NAT
ySP603 HTA2-CFP ura3 :pED45 WHI5 -mCitrine:HIS3
ySP568 HTA2-CFP ura3 :pED45 trp1 :pED73
ySP591 HTA2-CFP ura3 :pED45 YOX1 -mCitrine:HIS3
ySP570 HTA2-CFP ura3 :pSP303 trp1 :pED73 fus3Δ::NAT
ySP571 HTA2-CFP ura3 :pSP303 trp1 :pED73 kss1Δ::NAT
ySP572 HTA2-CFP ura3 :pSP303 trp1 :pED73 kss1Δ::KAN
fus3Δ::NAT
ySP569 HTA2-CFP ura3 :pSP303 trp1 :pED73
ySP560 HTA2-CFP ura3 :pSP323
yED92 HTA2-CFP ura3 :pSP323 ste11Δ::NAT
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yED87 HTA2-CFP ura3 :pSP323 bck1Δ::NAT
ySP37 HTA2-CFP
yED55 HTA2-CFP ura3 :pED45 leu2 :PFIG1-qVenus
yED56 HTA2-CFP ura3 :pED55 leu2 :PFIG1-qVenus
yED57 HTA2-CFP leu2 :PFIG1-qVenus
yED91 HTA2-CFP ura3 :pED55 trp1 :pED73
ySP492 HTA2-CFP ura3 :pSP306
yED67 HTA2-CFP ura3 :pSP306 bck1Δ::NAT
ySP558 HTA2-CFP ura3 :pSP321
ySP559 HTA2-CFP ura3 :pSP322
ySP556 HTA2-CFP ura3 :pSP319
ySP596 HTA2-CFP ura3 :pSP323 WHI5 -mCitrine:HIS3
ySP594 HTA2-CFP ura3 :pSP323 YOX1 -mCitrine:HIS3
ySP300 cdc28as
yED136 HTA2-iRFP-HIS
yED152 HTA2-iRFP-HIS ura3 :pED92
yED164 HTA2-iRFP-HIS ura3:pED92 leu2 :pED94
yED195 cdc28as HTA2-iRFP-HIS
yED238 HTA2-iRFP-HIS ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP
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yED253 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED137
yED254 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED138
yED255 HTA2-iRFP-HIS ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP bar1Δ::NAT
yED258 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP
yED264 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::NAT
yED275 cdc28as HTA2-iRFP-HIS WHI5 -mCitrine:TRP
yED281 cdc28as HTA2-iRFP-HIS ura3 :pED141
WHI5 -mCitrine:TRP
yED284 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED137 bar1Δ::NAT
yED285 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED138 bar1Δ::NAT
yED288 cdc28as HTA2-iRFP-HIS ura3 :pED141
WHI5 -mCitrine:TRP bar1Δ::NAT
yED289 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147
yED299 HTA2-iRFP-HIS ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP bar1Δ::NAT far1Δ::KAN
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yED300 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147 bar1Δ::NAT
yED306 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147 ste20Δ::NAT
yED307 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147 ste7Δ::NAT
yED310 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147
ste20Δ::pED159
yED311 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147
ste20Δ::pED160
yED312 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147
ste20Δ::pED161
yED313 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147
ste7Δ::pED162
yED314 HTA2-iRFP-KAN ura3 :pED92 leu2 :pED94
WHI5 -mCitrine:TRP ste5Δ::pED147
ste7Δ::pED163
yED316 cdc28as HTA2-iRFP-HIS ura3 :pED141
WHI5 -mCitrine:TRP ste5Δ::NAT
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yED321 cdc28as HTA2-iRFP-HIS ura3 :pED141
WHI5 -mCitrine:TRP ste5Δ::pED164
yED324 cdc28as HTA2-iRFP-HIS ura3 :pED141
WHI5 -mCitrine:TRP ste5Δ::pED164 bar1Δ::NAT
146
Table A.2.: Table of plasmids.
Plasmid Insert Backbone
pED45 PRPS2-Ste71−33-NLS-NLS-mCherry pRS306
pED53 PRPS2-STE71−33-NLS(S14A,S22A)-NLS(S14A,S22A)-mCherry pRS306
pED54 PRPS2-STE71−33-NLS(S14E,S22E)-NLS(S14E,S22E)-mCherry pRS306
pED55 PRPS2-STE7ND-NLS-NLS-mCherry pRS306
pED73 PRPS2-STE71−33-NLS-NLS-mCitrineA206K,L221K pRS304
pSP31 PFIG1-quadrupleVenus [86] pRS305
pSP198 PFus3-FUS3as [71] pRS406
pSP303 PRPS2-FAR1DS-NLS-NLS-mCherry pRS306
pSP306 PRPS2-MKK21−33-NLS-NLS-mCherry pRS306
pSP319 PRPS2-MKK21−27-NLS-NLS-mCherry pRS306
pSP321 PRPS2-MKK21−60-NLS-NLS-mCherry pRS306
pSP322 PRPS2-MKK21−80-NLS-NLS-mCherry pRS306
pSP323 PRPS2-MKK21−100-NLS-NLS-mCherry pRS306
pED92 PRPS6B-STE71−33-NLS-NLS-Cherry pSIVURA
pED94 PRPS6B-STE7ND-NLS-NLS-CFP pSIVLEU
pED137 STE5:HIS pGTHIS
pED138 STE58A:HIS pGTHIS
pED141 PRPS6B-STE71−33-NLS-NLS-mCherry
PRPS6B-STE7ND-NLS-NLS-CFP
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pED147 STE5ND:HIS pGTHIS
pED159 STE20ΝD:ADE pGTADE
pED160 STE2011A:ADE pGTADE
pED161 STE20CRIBΔ:ADE pGTADE
pED162 STE7ND:ADE pGTADE
pED163 STE76A:ADE pGTADE
pED164 STE5ND:ADE pGTADE
• NLS represents the peptidic sequence : QQMGRGSEFEELGSPLKKLKISPDTASGLV
• STE7 1−33 represents the peptidic sequence: MFQRKTLQRRNLKGLNLNLHPDVGN-
NGQLQEKT
• STE7ND represent the peptidic sequence: MFQRKTLQAANLKGANANLHPDVGNNGQLQEKT
• Far1DS represents the peptidic sequence: MFQRKTLQKRGNIPKPLNLSLHPDVGNNGQLQEKT
• pSIV and pGT backbone from [132]
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Modelling of MAPK activity from biosensor measurements. The table B.1 lists the reactions
Reaction Kinetic constant
SKARSCyto → SKARSCyto-P VMAPK , KMAPK
SKARSNucl → SKARSNucl-P VMAPK , KMAPK
SKARSCyto-P → SKARSCyto VPPase, KPPase
SKARSNucl-P → SKARSNucl VPPase, KPPase
SKARSCyto → SKARSNucl kImp
SKARSNucl → SKARSCyto kDiff
SKARSCyto-P → SKARSNucl-P kDiff
SKARSNucl-P → SKARSCyto-P kDiff
Table B.1.: Reactions implemented in the model.
implemented in the model. The sensors in the nucleus and in the cytoplasm are phosphorylated
by the MAPK. We assume simple Michaelis-Menten kinetics for this reaction. The dephosphory-
lation is also modelled by a Michaelis-Menten law. We assume that these enzymes are processive
and that the four phosphorylation events do not lead to ultra-sensitivity of the response. We
think this is a fair assumption since during the development of the sensor we tested constructs
with a variable number of phosphorylation sites and the general response of the sensor increased
almost linearly with this number. We consider the amount of phosphatase and their linked ac-
tivity to be constitutive. On the opposite, the MAPK activity changes with time. To account
for this, VMAPK is calculated as kCat*MAPK*MAPKActivity. MAPK represents the total con-
centration of the kinase estimated to 0.7μM (Fus3+Kss1 ~14’000 molecules/cell, volume of yeast
cell ~35fl). The parameter MAPKActivity varies between 0 and 1 and represents the fraction of
MAPK that is activated in the cell and thus can contribute to the phosphorylation of the sensor.
The sensor diffusion in and out of the nucleus has been estimated based on the formula: kDiff
= NPC/Na/Vn*p [123]. This determines the diffusion rate between nucleus and cytoplasm.
Using the nuclear accumulation of the non-functional sensor, we can estimate that the active
import of the sensor is 3.3 times larger than passive diffusion. The concentration of sensors was
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estimated to be relatively similar to the one of the MAPK (0.6 μM). For the starting condition,
it is enriched almost three folds in the nucleus. Kinetic parameters and starting concentrations
are listed in table B.2. For forward simulation of the model, the MAPKActivity evolves with time
according to the formula:
MAPKActivity =
A
1 + exp(−R(t− T0)) +O
A: Amplitude of the response, which varies from 0 to 1 in the different traces presented in
figure 2.10.A.
R: Rate of activation of the MAPK, set to 0.04
t: time axis
T0: Start time, set to 950s
O: Offset value, set to 0
The model is simulated for 1800s. Time 900 is set to 0 in the graphs from figure 2.10. A-B. The
first 500s (-900 to -400) allow an equilibration of the SKARS between cytoplasm and nucleus.
To extract the MAPKActivity based on experimental data, Matlab optimises the set of variables
defining the variation of the MAPKActivity with time (A, R, T0, O). For the dose-response
calculation (figure 2.11.A), we used the same equation as above. The nuclear to cytoplasmic
ratio to be fitted consists on five time-points before 0 set to the value of the active import
and eight time-points from 8 to 15 set to the nuclear to cytoplasmic ratio measured for one
concentration of the dose response. The final value of the MAPKActivity after simulation is used
as the steady-state MAPK ratio plotted in the dose response graph (figure 2.11.A).
To extract the MAPKActivity from the experimental data from Figure 2B a more complex
equation was used to account for the rise and decay in MAPKActivity:
MAPKActivity =
A1
1 + exp(−R(t− T0)) +
A2
1 + exp(−R(t− T0)) +O − 1
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A1 and A2: Amplitude of the response
R and D: Rate of activation (deactivation) of the MAPK
t: time axis
T0 and TD: Start time and Decay time
O: Offset value
The time axis and median value of nuclear to cytoplasmic ratio to the simulation. From an
initial starting set of parameters, the program optimises them to fit the experimental trace. The
outcome of the fit is presented in figure 2.10.C. The starting and final parameters are given in
table B.3.
Modelling of CDK-dependent MAPK activity From the NAPPI dose response experiment
presented in 3.2.5 we extract the MAPK activity and the CDK activity either prior (MAPKPreα,
CDKPreα) or after stimulation (MAPKPostα, CDKPostα) with α-factor for each individual cell.
The median of these parameters were calculated for each experiment including all replicates. We
plotted the data using a scatter plot showing the MAPK parameters against the CDK parameters.
We then used the fit function of matlab to fit our data. For the scatter plot of MAPKPostα against
CDKPostα we obtained the best fit using a polynome 2 equation (figure 3.20.C). For the scatter
plot of MAPKPostα against CDKPostα we obtained the best fit using a linear equation.
These two equations are then used to estimate the MAPK activity from the dynamic CDK
activity data. We use values of single cells from a completely independent experiment. The
estimated MAPK activity prior pheromone addition is defined as:
MAPK ′t50,CDK = A1CDKt50 +B1
Under stimulating condition:
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MAPK ′t>0,CDK = A2CDKt>0
2 +B2CDKt>0 + C2
Dynaminc single cell MAPK and MAPK’ values are then plotted against the time relative to
pheromone addition for comparaison (figure 3.21.A).
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Parameter Value Unit
VMAPK kCat x MAPK x MAPKActivity µM/s
KMAPK 0.5 µM
kCat 0.18 1/s
Vppase 0.1 µM/s
Kppase 0.5 µM
kDiff NPC/NA/VN*p ~ 0.05 1/s
NPC: number of nuclear pores ~ 160
NA: Avogadro’s Number 6.022 1023 1/mol
VN Volume of the Nucleus 3.5 fl
p: permissiveness of nuclear pores ~ 0.06 1/µM/s
kImp kDiff x RatioActiveImport 1/s
RatioActiveImport 3.3 -
MAPK 0.7 µM
MAPKActivity 0 -
SKARSCyto 0.43 µM
SKARSCyto 0.166 µM
Table B.2.: Kinetic parameters and starting concentrations
Parameter Initial guess Final value
A1 0.9 0.608
A2 1 0.772
R 0.01 0.041
D 0.2 0.0087
T0 850 856
TD 1500 1511
O 0.05 0.377
Table B.3.: Parameters describing the MAPK activity dynamics.
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Parameter Value
A1 -0.973
A2 -2.763
B1 1.579
B2 2.073
C2 1.217
Table B.4.: Equation parameters.
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On the histogram of the Whi5N/Cvalues we easily identify two populations: one with a low
Whi5N/C and one with a high Whi5N/C figure C.1
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Figure C.1.: Schematic representation of a his-
togram of the whole Whi5N/C . The
histogram includes all values from
all cells independently of the time.
The threshold value presented on
the scheme was indeed used to sort
cells.
.
In order to identify growth stages of cells
and to synchronise them, we set an arbit-
rary threshold between the two groups of cells
(threshold=2). After YeastQuant analysis,
the RatioN/C of the Whi5 channel is organised
as a matrix of values where each column cor-
responds to one cell and each row correspond
to one time point. We first transform the mat-
rix in a matrix of binaries where 1 is above
the threshold and 0 is below this threshold.
We named this matrix Binthre. We focus on
Binthre values spanning from the first time-
point until the time-point of pheromone ad-
dition. Cells which have only ones are con-
sidered as starting the time lapse in G1. Cells
having only zeros are considered as starting in S-G2-M. The same strategy was used to identify
G1-locked cells and the S-G2-M cells except that we consider all time points. G1-locked and
S-G2-M cells are extracted from dataset.
We recover Binthre to identify the cell entering in G1 or in S-phase and passing through G1.
Two vectors (V1=[0 0 1 1], V2=[1 1 0 0]) are created and are used to scan Binthre along the
time axes. In a zeros matrix of the same size as Binthre, further referred as MatPos, a value of
1 is assigned at the position where V1 is matching Binthre (or -1 for the vector V2). Column
containing 1 is considered as cell entering in G1 (in S if -1). If one column contains a -1 and
1 the cell is considered as passing-through G1. For the cases where a column contains more
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than 2 values different from 0 the cell is totally rejected from the analysis. Depending on, the
experiment, our criteria can reject until a maximum of 5% of the total population.
The position of the -1 and 1 into the matrix Binthre indicate when the cell transit from one
stage to another. The vector time of each cell entering in G1 is recovered and and time 0 changed
based on the position of the -1, 1 into the Binthre matrix.
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